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Around 30% of the general population report having occasional sleep disturbances 1-3. 
Sleep disturbances may involve having trouble initiating or maintaining sleep, waking up 
too early, or suffering from nonrestorative sleep1,2. Prevalence rates drop to around 18% 
in case the criterion applied is that the sleep disturbance has to be present for at least 3 
nights a week. With the additional criterion that the sleep disturbance must cause clinically 
significant distress or impairment, prevalence rates drop to 10% of the general population2. 
Around 6% of the general population suffer from a diagnosis described in the Diagnostic 
and Statistical Manual 5th edition (DSM-V4) under the category Insomnia Disorder: one 
or more of the abovementioned symptoms for at least 3 nights a week in the last 3 months, 
which cause significant distress or impairment, and are not caused by other sleep or mental
disorders or by substance use. The opposite of insomnia is commonly known as hypersomnia, 
which occurs in around 3% of the population. This disturbance refers to excessive sleepiness 
despite a main sleep period of at least 7 hours, either by recurrent daytime sleep episodes, 
by prolonged sleep episodes of > 9 hours per day, or by difficulty being fully awake after 
abrupt awakening. These symptoms must occur at least 3 times a week for at least 3 months, 
must cause clinically significant distress or impairment, and should not be caused by other 
sleep or mental disorders or by substance use to be diagnosed with the DSM-V category 
of Hypersomnolence Disorder4. Dissatisfaction with subjectively assessed sleep quality or 
quantity showed comparable prevalence rates as insomnia symptoms that occur at least 
3 nights a week: around 19% of the general population reported dissatisfaction with sleep
quality or quantity1. Sleep disturbances are closely related to impaired emotional and cognitive 
functioning5 such as decreased emotional intelligence and declined constructive thinking 
skills6. Individuals with sleep disturbances are also more likely to report poorer health, and 
make greater use of healthcare1. In 40% of individuals with sleep disturbances their sleep 
disturbance co-occurs with a mental disorder7, whereas only 16% of individuals without
sleep disturbances suffer from a mental health disorder1-3. Most research on sleep 
disturbances and mental health disorders has been focused on Major Depressive Disorder
(MDD). This is not surprising, because MDD is strongly associated with sleep disturbances8. 
Sleep disturbances are part of DSM-V MDD’s diagnostic criteria4 (Box 1) and are present in 
approximately 70% of MDD patients8,9. Next to that, sleep disturbances are known to be an 
underlying risk factor for developing MDD3,10-12. Suffering from insomnia doubles the risk 
to develop MDD13. Sleep disturbances often persist after remission of MDD. Around 40% of 
patients report sleep disturbances during periods of remission9, and it is well-known that 





MDD is one of the most common and debilitating mental health disorders in the Western 
world15. Worldwide, MDD is ranked as the 4th leading cause of disability by the World 
Mental Health Organization, and it has been predicted to rise to the 2nd place by 202016. 
Lifetime MDD prevalence rates range from 1 to 19% for different countries, with a twice 
as high lifetime risk to develop MDD for women compared to men. The course of MDD 
is often chronic-recurrent16. Up to 35% of MDD patients do not respond well to available 
treatment. Partial response, meaning 25-49% symptom reduction from baseline, occurs in 
around 15% of MDD patients. Conradi et al.9 showed that MDD patients report on average 
two residual symptoms out of the nine DSM-V depressive symptoms during periods of 
remission, of which sleeping disturbances are present in around 40% of the occasions. 
Residual symptoms such as sleep disturbances have been associated with a 3.5 times higher 
risk of recurrence compared to patients that achieved full remission17. However, treatment 
until full remission is achieved is not common practice9. 
Box 1. MDD symptoms according to DSM-V.
(1) Depressed mood most of the day, nearly every day, as indicated by either subjective report or 
observation made by others. 
(2) Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every 
day.
(3) Significant weight loss when not dieting or weight gain, or decrease or increase in appetite nearly 
every day. 
(4) Insomnia or hypersomnia nearly every day. 
(5) Psychomotor agitation or retardation nearly every day. 
(6) Fatigue or loss of energy nearly every day. 
(7) Feelings of worthlessness or excessive or inappropriate guilt nearly every day. 
(8) Diminished ability to think or concentrate, or indecisiveness, nearly every day. 
(9) Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide  
attempt or specific plan for committing suicide. 
Despite the attention that has been paid to the development of MDD treatment, a 
favorable impact on MDD prevalence in the population has not been detected18. A potentially 
influential factor that might have contributed to MDD treatment being insufficient is the 
underestimation of sleep disturbances in the treatment of MDD. Previous studies have 
learned us a lot about the potential risks of sleep problems, the large burden of major 
depression, and how sleep problems and major depression can exacerbate each other over the 
years. However, although sleep has been acknowledged as an important factor with regard 
 to the development and recurrence risk of MDD, interventions concerning sleep are often 
neither included nor mentioned in MDD treatment guidelines and protocols19. 





is that it is not well understood what the exact role of sleep is in MDD. Earlier studies on 
the role of sleep in MDD have been focusing on the effect of sleep at a time scale with long 
intervals, for example to investigate the influence of present sleep disturbances on the 
development of MDD one year later20. This type of studies is interesting and informative 
regarding the etiology of MDD. However, the long time-interval in this type of studies 
disables the possibility of investigating short-term changes that occur in MDD and exploring 
more precisely the temporal order at which these short-term changes occur. Studies with 
shorter time intervals and multiple repeated assessments are needed to investigate the 
temporal order of change among sleep and other relevant factors that are involved in 
MDD such as affect21, physical activity22, and melatonin23. Identifying the temporal order 
of change between sleep and these factors implicated in MDD matters, because knowing 
where change starts enables to indicate potential starting points in the treatment of MDD. 
This may help to identify the potential of targeting sleep parameters in the prevention and 
treatment of MDD.  
There are some other methodological factors that have complicated MDD research. 
These factors are inherent to ‘traditional’ research approaches, by which I mean studies 
with a cross-sectional design, or panel design with a limited number of assessment waves, 
or studies that are performed in a laboratory setting. These studies do not connect well 
to what happens in clinical practice and the daily life of MDD patients for the following 
reasons: (1) dynamics are not captured, (2) heterogeneity among patients is not accounted 
for, and (3) ecological validity is low. I will discuss each of these problems in more detail 
below.
Dynamics
Change over time is one of the main characteristics of how affective disorders evolve24. 
Processes that are characterized by change, activity, or progress are called dynamic 
processes. It is known that MDD has a dynamic character25. MDD symptoms, affect, 
and underlying factors that are closely related to MDD, fluctuate from day to day21. Not 
knowing how short-term fluctuations in MDD-related variables (e.g., affect, cognitions, 
behavior, hormones) are related to each other and in what order they occur hampers 
progress in scientific research and MDD treatment because it leaves limited insight in day-
to-day fluctuations and mechanisms involved in MDD. To uncover the temporal dynamics 
and the ebb and flow of variables involved in MDD, and to answer questions about the order 
in which fluctuations among MDD-related variables occur, it is necessary to perform 
studies with multiple repeated assessments that are frequently assessed at short time 
intervals26. Modeling short-term dynamics and the order of change over time has the 
potential to give a clearer insight in processes that evolve in MDD and provides potential 
starting points in the treatment of MDD. 
Heterogeneity
The diagnostic guideline of MDD was based on descriptions of clinicians instead of 
empirical research, and has resulted in a very heterogeneous concept of the disorder27,28. 





of which one must be a core symptom, to be diagnosed with MDD according to the 
guidelines of the DSM-V4 (criteria see Box 1). This means there are up to 227 possible 
symptom combinations for a diagnosis of MDD29. Heterogeneity was even described as 
“the most salient feature of depression”30. The problem is that when such heterogeneous 
population of depressed patients is investigated at the level of the group, significant 
information about the variation among individuals is cancelled out. This has hampered 
adequate prediction of MDD outcomes in clinical practice31, because an average 
representation of MDD patients cannot reflect the heterogeneity that is seen in clinical 
practice. Heterogeneity is not well accounted for in traditional studies because their focus 
is on average group results. This means that the average results that emerge from traditional 
research approaches do not mirror the actual behavioral patterns of MDD patients32. Studies 
with multiple repeated assessments are suitable to overcome this problem because such a 
design enables to take interindividual heterogeneity into account while group-level effects 
can still be estimated. 
Ecological validity
A third difficulty in MDD research is the low ecological validity of some traditional studies. 
Ecological validity can be low because of several reasons: retrospective assessments, an 
unnatural setting, not taking environmental context into account, and the type of de-
sign that disables to model fluctuations over time at the person-level33,34. This restricted 
ecological validity decreases the translatability of study results to the daily life of 
participants. Although a traditional approach is informative to classify certain characteristics 
of a group, it is a disadvantage not to know how patients behave and feel in their own 
environment. Especially in light of the heterogeneous and dynamic character of MDD 
and the daily fluctuations of MDD symptoms and MDD-related variables, it is of great 
informative value to capture the flow of daily life in which MDD-related factors develop and 
change in the participant’s natural environment. 
Aim of this thesis
In this thesis the role of sleep is investigated in the context of everyday MDD from a 
physiological and a behavioral perspective by means of intensive longitudinal designs and 
relatively novel statistical techniques. Intensive longitudinal designs refer to a research 
approach in which series of multiple repeated measurements are collected within each 
individual. Intensive longitudinal designs result in time series: repeated assessments 
per individual over time. Ideally these repeated assessments are measured within a time 
frame that fits the process of interest, i.e. a short, within-day time interval to capture 
fluctuations in hormones, and a longer, between-day time interval to capture fluctuations 
in sleep. 
 





relevant complementary knowledge about the dynamic role of sleep32,34. This enables 
to answer questions about the temporal order of change during a dynamic process from 
several perspectives. For example, time series with within-day measurements enable to 
assess dynamics of a biomarker such as melatonin because fluctuations of the biomarker 
are expected to occur at a short time scale. Time series with daily measurements enable 
to assess dynamics of sleep. Lastly, time series with week-to-week measurements enable 
to examine fluctuations in symptoms of depression because symptoms are less likely to 
fluctuate much within the day. 
An extra advantage of time-series data is the possibility to characterize person-specific 
 processes, as the data can be analyzed at the level of the individual. Besides, the design 
with repeated assessments allows testing average patterns at the level of the group, while 
still taking differences among individuals into account. Therefore, this approach is very 
suitable to identify communalities as well as differences among patients, which may help to 
overcome the problem of heterogeneity among MDD patients26,32. 
Third, in intensive longitudinal designs most often ambulatory assessments are used 
to frequently assess participants within the context of their daily life. Ambulatory assess-
ments cover a wide range of assessment methods to study people in their natural environ-
ment: for example self-report of depressive symptoms, affect, or sleep, objective monito-
ring of physical activity, and collection of biomarker data34. These assessments that occur 
in a natural and spontaneous context increase the ecological validity and thus translata-
bility of study findings to daily life and clinical practice. To conclude, by using intensive 
longitudinal designs we can address dynamics, heterogeneity, and ecological validity while 
investigating the role of sleep from a physiological and a behavioral perspective. 
In Chapter 2 and Chapter 3, the role of sleep is viewed from a physiological perspective. 
In Chapter 2 I describe how endogenous melatonin secretion develops over time. Therefore 
stability, within- and between-day dynamics, and interindividual differences of endogenous 
melatonin secretion in MDD patients and healthy controls were investigated. Chapter 3 
describes how these within-day dynamics of melatonin secretion are connected to within-
day dynamics of positive affect, negative affect, and fatigue, and vice versa. Besides, in 
this chapter, the association between interindividual differences in the role of melatonin 
secretion and depression severity and sleep-related factors was explored. 
In Chapter 4, 5 and 6 I explore the role of sleep from a behavioral perspective. Chapter 
4 describes the within-day temporal order of changes in sleep and affect in MDD patients 
and healthy controls, and whether these changes are mediated by fatigue or rumination. 
Chapter 5 describes the within-day temporal order of changes in sleep and physical activity 
 in MDD patients and healthy controls, and whether these dynamic associations are the 
same for MDD patients and healthy controls. In Chapter 6, the bidirectional dynamic week-
to-week association between sleep symptoms and core depressive symptoms in MDD 
patients is described and attention is paid to data-driven subgroups that differ based on the 
3-year course of these symptoms. 
Chapter 7, the General Summary and Discussion, is dedicated to the discussion of the 
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Disrupted melatonin secretion is regarded as a link between circadian rhythm and 
major depression, but results have been contradictory. We hypothesize that this 
might be due to averaging across individuals and too short measurements periods. 
In this study, pair-matched depressed and non-depressed individuals sampled 
saliva three times a day, 30 days, in their natural environment. The depressed group 
showed significantly more variance and higher melatonin levels (p < 0.05). Substantial 
interindividual heterogeneity and day-to-day variability was found. The individual time- 
series approach allowed us to reveal this variability. Important information remains 
unnoticed when analyzing melatonin only at the group level. 
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The impact of biological rhythm disruptions on mood disorders has received a lot of 
attention over the past years. A key hormone in the synchronization of the biological 
rhythm is melatonin1-3. Depressive disorders have been associated with markedly lower 
melatonin levels compared with healthy controls4 but the literature is not entirely 
consistent: both decreased and increased levels of melatonin have been reported in 
patients with depressive disorders5. Treatments targeting the biological rhythm, such 
as sleep deprivation and light therapy, have been proven effective in some, but not all, 
depressed patients6,7. The exact nature of the relationship between melatonin levels and 
depressive symptoms has remained largely unclear. 
One limitation of the studies to date is that melatonin levels are usually aggregated over 
individuals and presented as group averages – an approach referred to as the nomothetic 
 approach8. This approach implicitly assumes that the same model holds for all individuals, 
resulting in loss of information on individual secretion patterns when this assumption 
does not hold. As an alternative, time-series designs with multiple repeated measurements 
have been suggested to investigate dynamic patterns within individuals (idiographic 
approach)9. This approach has not yet been applied on melatonin data. 
A second shortcoming of previous studies is the short time period during which 
melatonin is assessed. Up to now, most studies on melatonin have been performed over a 
period of 24 hours or less, in which only one secretion cycle of melatonin can be covered at 
the most10. The implicit assumption here is that secretion patterns are the same for every 
24 h. In case of large day-to-day variability, single-day assessments will yield unreliable 
information. Multiple-day assessments of 24-h melatonin levels have been performed before, 
for example, to study the consistency of plasma melatonin levels between days of different 
menstruation phases11. In such  a design, however, measurement days are not sequential 
but interrupted. Consecutive measurements during a more prolonged time period may 
provide different information12. To the best of our knowledge, no naturalistic studies have 
measured melatonin for a prolonged time period yet.
We documented the temporal characteristics of longer-term daytime melatonin secretion 
 patterns in pair-matched depressed and non-depressed individuals, using a replicated 
single-subject time-series design. We examined mean levels, variability and stability of 
individual melatonin secretion and explored potential differences between depressed and 
non-depressed individuals.
Materials and Methods
This study is part of the Mood and Movement in Daily Life (MOOVD) study. The MOOVD 
study investigates the dynamic relationship between physical activity and mood, and its 
underlying physiological processes, in depressed and non-depressed individuals. Using 
detailed repeated assessments, this study allows us to investigate the temporal patterns in 
2




physical activity, hormone secretion and  depressed mood, individual differences therein, 
and clues for tailor-made interventions. A replicated single-subject time-series design was 
used, in which pair-matched depressed and non-depressed individuals were monitored for 
30 days within their natural environment, three times a day. Participants filled out electronic 
diaries, wore an accelerometer, and sampled saliva at each assessment point, resulting in 
time series of up to 90 repeated measurements per individual.
Subjects
We selected the first 10 depressed individuals and 10 matched non-depressed controls of the 
MOOVD study for the present analyses. This number suffices to provide a valid reflection 
of between-subject variations and detect relevant effect sizes (ES > 0.5) with adequate 
power, while still allowing a detailed description of individual time series. The participants 
were included in the period January 2012 until June 2013 and pair-matched based on gender, 
age, smoking status, and body mass index to facilitate pair-wise comparison. Depressed 
individuals were recruited from a patient population of the University Center of Psychiatry 
(UCP), University Medical Center Groningen and from the Center for Integrative Psychiatry. 
This resulted in the inclusion of eight outpatients and two inpatients. Non-depressed 
individuals were recruited from the general population. Inclusion criteria for the non- 
depressed group were Beck Depression Inventory (BDI13) score <9 and absence of DSM-IV 
major depressive disorder (MDD), and for the depressed group BDI score >14 and MDD 
(current or recent; <2 months). The presence of MDD was established in those who met 
inclusion criteria on the BDI by means of the Composite International Diagnostic Inter-
view (CIDI14). All participants had regular sleep-wake schedules (i.e. no night-shift workers) 
and were capable of following the research procedure for 30 days, i.e. keeping an electronic 
diary three times a day, sampling saliva while filling out the electronic diary, abstaining 
from eating or drinking (except water) during 30 min before sampling and wearing an 
accelerometer 24 h a day. Exclusion criteria were: current or recent (<2 years) episode of 
a psychotic or bipolar disorder, visual or hearing impairments, and pregnancy. The study 
protocol was approved by the local medical ethics committee and performed in accordance 
with the ethical standards laid down in the 1964 Declaration of Helsinki. All participants 
gave written informed consent prior to inclusion in the study. The protocol is conform to 
international ethical standards15. 
Study design
Saliva was sampled at three fixed time points a day (every six h) during a 30-day period 
in the participants’ natural environment resulting in a maximum of 90 melatonin 
measurements per individual. Saliva sampling was chosen because the long measurement 
period combined with the naturalistic design did not allow for repeated blood sampling. 
The time of the evening saliva assessments was set at 30 min prior to the regular bedtime 
(as assessed by the Munich Chronotype Questionnaire16), to avoid interference with the 
natural sleep pattern of the participants. For most participants, this resulted in assessments 
 at the end of the morning (mean ≈ 1000h), afternoon (mean ≈ 1600h), and evening (mean ≈ 
2200h). Nocturnal melatonin measurements were not collected because of the high burden 
of interrupting the participants’ sleep patterns. The individuals were warned by an alert 
2




30 min before every saliva sampling moment, and instructed not to eat, drink (apart from 
water), smoke, or brush their teeth until saliva was collected. An electronic diary was 
completed containing check-up questions to control whether the individual complied with 
the food and beverage restrictions over the previous 30 min. Individuals were instructed to 
collect saliva by keeping a Salivette® in their mouth for approximately 3 min while filling 
out the electronic diary. After saliva collection, the individuals were instructed to store the 
Salivette® in their refrigerator immediately if possible, and otherwise at least within 4 h 
after sampling. A logbook was provided to note abnormalities and protocol violations in 
sampling, for example changes in sampling time, extra medications taken that day, and 
being ill.
Electronic diaries were collected using the PsyMate®, an electronic device that was 
developed to facilitate the monitoring of daily life behavior (PsyMate BV, Maastricht, The 
Netherlands). The PsyMate® generated an alert every time the diary had to be completed. 
Questionnaires about mood, sleep, activities and cognitions influencing physical activity 
and mood such as social interactions, important events, rumination and self-esteem, were 
monitored with the PsyMate®. 
Accelerometers, the ActiCal®, were used throughout the total study period for objective 
measurement of physical activity by means of registering the participant’s energy expenditure 
(Respironics, Bend, OR).  The ActiCal® was continuously worn on the wrist of the non- 
dominant arm.
Melatonin assays
The saliva samples were centrifuged weekly and stored at -80°C until analysis. Liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) was used to analyze all samples. 
LC-MS/MS has broad analytic compatibility and high analytical performance17. Melatonin 
 was analyzed by means of online-solid phase extraction in combination with isotope 
dilution LC-MS/MS. In short, 250uL of saliva was used for the analysis and deuterated 
melatonin was used as internal standard. All samples of one individual were assayed in 
the same batch. Mean intra- and inter-assay coefficients of variation were below 9.0%. 
Quantification limit for melatonin was 5.0 pmol/L. 
Statistics  
All statistics were performed using IBM SPSS Statistics 20 (IMB, SPSS Inc., Chicago, IL). 
Linear mixed model analyses were used to compare the melatonin levels of the depressed 
and the non-depressed group, using all observations. The same was done for morning, 
afternoon, and evening levels separately. Bootstrapped confidence intervals were used to 
account for skewness in the distribution of melatonin values. We also conducted Levene’s 
test for homogeneity of variances to compare the variances in the depressed and non- 
depressed group. The level of significance was p < .05 for all analyses. 
For each individual, the mean square successive difference (MSSD), that is, the 
average of the squared differences between successive observations, was calculated to 
investigate day-to-day variability in melatonin levels18. This was done for morning, 
afternoon and evening levels separately. We used autoregressive integrated moving 
average (ARIMA) modeling19 to examine the degree of autocorrelation in the individual 
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time series. Autocorrelation reflects the stability of the melatonin secretion patterns. 
Morning and afternoon dummies were added to the models to control for daily cycles 
(reference category = evening) and a time variable was added to account for time trends 
in the series. Variables for medication use (1 for medication use, 0 otherwise), medication 
change (1 for change in medication use, 0 otherwise) and illness (1 for sick days, 0 otherwise) 
were used to model exogenous influences related to (changes in) medication use and 
illness. Optimal model specification of the ARIMA models was determined by inspection 
of the (residual) autocorrelation function and the Bayesian Information Criterion (BIC). 
Backward selection was used to remove non-significant control variables. Outlier values 
higher than three times the standard deviation of the noise residuals were accounted for 
by adding an outlier dummy variable (1 at the time point of the outlier, 0 otherwise) to the 
model. The white noise assumption (no residual autocorrelation) was tested with the Ljung-
Box test. The assumption of normally distributed residuals was tested with the skewness 
test. A log transformation was applied to the melatonin values in case this assumption was 
violated. The models were adjusted, re-estimated, and re-evaluated until both assumptions 
were met. 
Results
Group-level characteristics of depressed and non-depressed participants
Demographic, clinical and melatonin characteristics can be found in Table 1. The bootstrapped 
linear mixed model analyses showed that melatonin levels were significantly higher 
in the depressed compared to the non-depressed group (B = 87, 95% CI 56-123, p = 
.002). The same was true for the afternoon (B = 19, 95% CI 11-28, p = .003) and evening 
 (B = 166, 95% CI = 95-261, p = .013) melatonin levels separately. A trend toward sig-
nificance was shown for the morning levels (B = 77, 95% CI 37-125, p = .051). 
Levene’s test showed significant differences in the variances for morning, afternoon, 
 and evening melatonin levels between the depressed and the non-depressed group (p < 
0.001 for the three measurements).
Individual patterns of melatonin time series
Mean levels
The individual melatonin time series are visualized in Figure 1. Large interindividual 
differences in mean levels and standard deviations were observed for all 3-day segments, 
with mean levels ranging from 0 to 1397 and standard deviations from 0 to 2171. 
For most participants, evening values were significantly higher than morning and 
afternoon values, as expected. Exceptions were participants C3, C6, D6, D7, and D10. Note 
that participant numbers starting with a D refer to depressed participants and numbers 
starting with a C to their non-depressed matched controls. 
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Table 1. Demographic, clinical, and melatonin characteristics
Non-depressed (N = 10) Depressed (N = 10)
Female, n 7 7
Age, y 36.7 (7.9) 36.4 (10.3)
BMI, kg/m2 22.2 (2.3) 23.9 (4.9)
Non-smoker, n 10 10
BDI at intake 2.9 (3.4) 30.7 (10.9)
Morning melatonin, pmol/L
    Mean (SD)






    Mean (SD)






    Mean (SD)





Missing obs, % 7.6 (7.4) 2.3 (2.3)
Note. Age, BMI, BDI at intake, and missing obs are expressed as mean (SD). BMI = Body Mass Index; 
BDI = Beck Depression Inventory; missing obs = missing observations; IQR = Interquartile Range.
The afternoon melatonin levels were usually close to 0, except for those of participants 
C6, D7, and D8. For D8, this could be explained by nocturnal intake of the antidepressant 
citalopram (B = 753, 95% CI 466-1039, p < .001). The extraordinarily high-afternoon levels of 
C6 and D7 could not be explained by medication use or illness.
Mean morning values were highest for D6 and D7. The high-morning values of D6 
starting at day 24 could be explained by nocturnal amitriptyline intake, starting at day 23 
of the research period (B = 4517, 95% CI 387-514, p < .001). We found no explanation for the 
high-morning values of D7.
Variability
The estimated MSSDs indicated substantial day-to-day variability, particularly for the 
evening values, though not for all individuals and not for all day segments. For D2, D6 and 
D7, the day-to-day variability was highest for morning values and D10 showed the highest 
variability for afternoon values. Depressed individuals mostly showed higher day-to-day 
variability than their non-depressed matched controls, except for pairs 2, 3 and 6. 
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Figure 1. 30-day melatonin secretion patterns of depressed (D) and non-depressed (C) individuals
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Moderate to large autoregressive effects were found in three non-depressed individuals 
(C2: 0.57, C4: 0.34, C6: 0.26, p < .05) and three depressed individuals (D4: 0.50, D5: 0.27, D7: 
0.24, p < .05), in most cases at lag 3, indicating that current melatonin levels are predicted 
by previous-day levels in these individuals. Otherwise we found no significant autocorre-
lations. 
Discussion
Our investigation of individual longitudinal melatonin secretion patterns revealed 
systematic group-level differences between the depressed and non-depressed group. The 
depressed group showed higher mean levels and also more variance in melatonin levels 
compared to the non-depressed group, probably due to extreme heightened melatonin 
levels in some individuals of the depressed group. Above that, we found important inter- and 
intra-individual variability in melatonin secretion patterns, which would have remained 
unnoticed if the focus were exclusively on aggregated group results. 
One of this study’s strengths is the detailed information collected about individuals’ 
 melatonin secretion pattern over a period of 30 days. This information allowed us to 
show large interindividual differences in mean levels, variance, day-to-day variability and 
stability, as well as large intra-individual variability of melatonin secretion. Our results 
emphasize the added value of using a replicated single-subject time-series design, as 
mentioned before9,12. Inconsistencies in the literature5 as well as small overall effect sizes 
in group-based studies can be interpreted in the light of the heterogeneity revealed by our 
study. Large intra- and interindividual differences can account for substantial variations in 
study results, depending on the sample and the time of assessment. 
Some individuals in the depressed group showed extreme heightened melatonin levels. 
This in contrast to most studies, where depressed patients seem to show overall lower 
melatonin levels compared with healthy controls4. However, higher levels of melatonin in 
depressed patients have been reported as well5, and  earlier studies have suggested that 
elevated levels of melatonin might be due to different clinical characteristics between 
participants. Another factor that might be of influence on melatonin secretion levels is 
drugs use: after taking the influence of drug use into consideration, melatonin levels of 
depressed patients have been shown to be lower than melatonin levels of healthy controls20. 
The antidepressants citalopram and amitriptyline had a clear influence on melatonin 
 levels in this study. Both antidepressants were developed to inhibit synaptic serotonin 
reuptake, and serotonin is a precursor of melatonin21,22. It may therefore be argued that 
melatonin secretion is increased by the SSRI-induced suppression of synaptic reuptake of 
serotonin. Interestingly, imipramine and sertraline, acting comparably to citalopram and 
amitriptyline, were not found to affect melatonin levels in this study. Citalopram, amitriptyline 
and imipramine were taken after the evening measurement, and sertraline was taken before 
the morning measurement. In light of the circadian rhythm of melatonin secretion, the 
2




time of intake might mediate the effect of antidepressants on melatonin secretion. These 
possibly differential side effects of SSRIs might have clinical implications, particularly for 
depressed patients who suffer from a disturbed biological rhythm, and are additionally 
treated with light therapy. 
Diet can have an influence on melatonin levels as well, though the influence of diet is 
minor compared with that of light23. Food with a high concentration of tryptophan provides 
 an environment that is needed for the production of melatonin, but several vitamins and 
minerals have to be present to activate this production process24. Studying participants 
in their natural environment makes it hard to control their diet. However, in the current 
study, participants were instructed not to consume any food or beverages (except for water) 
within 30 min prior to the saliva sampling. 
A limitation of our study was that we did not measure melatonin during the night. 
Technological advancement may make it possible to include nocturnal melatonin 
measurements in future studies. It remains to be investigated why melatonin levels 
can differ so substantially between individuals. In addition to medication use, possible 
contributors to this heterogeneity in melatonin levels include sleep, exercise and nutrition. 
To fully understand their relationships with melatonin, it is important not to focus on each 
of these factors separately, but to examine their interdynamics over time. 
This is the first study that shows the potential of individual time series for the 
exploration of inter- and intra-individual variability in melatonin secretion. The substantial 
 heterogeneity, both across and within groups, and the large day-to-day variability within 
individuals emphasize the need to account for individual heterogeneity and temporal 
complexity in endocrinological studies. 
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The aim of the present study was to reveal how positive affect (PA), negative affect (NA), 
fatigue, and melatonin are inter-related in individuals with and without MDD.  
We used a unique dataset with up to 90 measurements of 14 depressed and 15 pair- 
matched non-depressed participants and the novel network analysis approach Group 
Iterative Multiple Model Estimation (GIMME) to reveal how affect, fatigue, and melatonin 
were related across time at the group- and individual level. Thereafter, we investigated how 
individual-level differences in the role of melatonin were related to sleep and depression 
severity. 
PA and NA (β=-0.47), and PA and fatigue (β=-0.44) were related contemporaneously in 
the full sample. Substantial between-individual differences were found. In 83% of the study 
participants, melatonin was related to either affect or fatigue. Those who did not have 
associations with melatonin in their networks had relatively greater depression severity, 
worse sleep quality, and lower energy expenditure. 
This study revealed the possibilities of network mapping (via GIMME) for dynamic 
individual psychological and biological data. The results underline not only the presence 
of large heterogeneity, but also show that despite this heterogeneity, meaningful 














Major Depressive Disorder (MDD) is one of the most common and debilitating mental 
 health disorders in the Western world1. Depression has intricate ties with sleep, as 
up to 80% of patients who suffer from MDD also report sleep disturbances (insomnia, 
hypersomnia, or both) during a depressive episode2. Yet, little is known about the 
mechanisms underlying the link between MDD and sleep. In particular, it is unclear how 
depression-related factors, such as affect, and how sleep-related factors, such as fatigue 
and melatonin levels, are inter-related. This knowledge gap could be due to a lack of 
longitudinal data and analytic techniques necessary for unraveling these inter-relations. 
Several theories suggest that disturbed sleep and depressed mood are both a 
physiological response to a disruption in circadian rhythms3,4. The circadian rhythm is 
colloquially referred to as the biological clock. Light helps to keep the biological clock in 
sync with humans’ external 24-hour cycle of day and night5,6. Light sends signals to the 
pineal gland via the retina and the suprachiasmatic nucleus, and the pineal gland regulates 
 the synthesis of melatonin3,7. The 24-hour cycle of melatonin synthesis is known to be 
responsible for the regulation of body temperature, metabolic activity, and sleep rhythm8,9. 
Changes in sleep rhythm are closely connected to disruption or changes of melatonin 
synthesis10. 
Mood-related processes are thought to be influenced by the circadian rhythm as well. 
A disrupted circadian rhythm has been suggested to change affect via a dysregulation of 
the neurotransmitter serotonin11,12. In the absence of light, serotonin is processed into 
melatonin within the pineal gland7,13. Exogenous administration of melatonin has been 
found to be effective in the treatment of mood disorders. Administration of slow-release 
melatonin decreased depression scores14, and melatonin agonists showed a reduction in 
depression scores15-17. Less clear is the association between endogenous melatonin levels 
and affect18.
Fatigue, often present during MDD, is known to influence affect19, and has been 
thoughto be associated with melatonin secretion too13,20,21. Earlier studies show 
contradicting results: in one earlier study manipulated suppression of melatonin by light 
did not influence fatigue scores20, but in another study the administration of melatonin 
 was associated with a significant increase in evening fatigue21. Up to know it is still 
unknown whether natural fluctuations in melatonin influence experienced fatigue, and 
vice versa.
The abovementioned paragraph show that several uncertainties have remained about 
the associations among melatonin, affect, and fatigue in the context of MDD, and the role 
of sleep therein. Although it is thought that abnormalities in circadian rhythmicity are 
reflected by changes in affect11,14,16-18 and fatigue13,20,21, it remains unclear how 
endogenous melatonin is related to these changes. Furthermore, it is not clear if and how 
depression and sleep are related to these associations among melatonin, affect, and fatigue. 
The daily fluctuations in affect22, melatonin23, and fatigue24,25, and individual 
differences therein, make it complex to investigate their associations over time. The 











accurately model complex relations such as these. GIMME maps the covariation among 
variables, revealing a network that shows how variables are related across time at the group- 
and individual level. Although GIMME was developed to model connectivity among brain 
regions of interest26, it has also been applied to behavioral data from clinical populations 
to reveal, for example, the inter-relations among facets of internalizing and externalizing 
behavior reported in the daily diaries of individuals with personality pathology27. The 
current use of GIMME to uncover the associations among dynamic psychological (e.g., 
affect) and biological (e.g., melatonin) variables is a novel method that fills a substantive 
gap in the literature concerning the mechanisms underlying MDD and sleep disturbances. 
Thus, the current study used a unique data set, consisting of up to 90 measurements from 
each of nearly 30 participants, and a novel network analysis approach to unravel how affect, 
fatigue, and melatonin are related in individuals with and without MDD.
The first aim of the present study was to identify the role of melatonin in moment- 
to-moment changes of affect and fatigue in depressed patients and healthy controls. Based 
on earlier literature we expected that fatigue, affect, and melatonin would be associated 
with one another at multiple time scales. However, due to the many uncertainties in the 
literature, we did not have hypotheses about the directions and signs of these associations. 
Second, we investigated how individual-level differences in the role of melatonin were 
related to sleep and depression severity. Again, we expected associations based on earlier 
literature, but were unsure about the signs of these associations.
Methods
Participants
We used a subsample of data from the Mood and Movement in Daily Life (MOOVD) 
study, a study that was created to investigate dynamics between physical activity, mood, 
and physiological processes in patients with and without MDD. Participants monitored 
themselves for 30 consecutive days, 3 times a day, by completing electronic diary questions, 
wearing an accelerometer 24/7, and providing saliva samples at every assessment point. 
This resulted in a maximum of 90 measurements per participant. 
Participants were included from January 2012 until May 2014 in the Northern part 
of the Netherlands, resulting in a total of 54 participants that completed the study. The 
subsample consisted of the 15 first depressed and 15 pair-matched non-depressed 
participants that completed the study. Depressed and non-depressed participants were 
pair-matched based on gender, age, smoking status, and body mass index to enable pair- 
wise comparison and in order to create comparable groups. Depressed patients were 
recruited in the patient population. The non-depressed participants were recruited from 
the general population with advertisements in public places and on social media. 
Depressed participants were included if they reported a score > 14 on the Beck 
Depression Inventory (BDI28), and if a current or recent (<2 months) episode of DSM-IV 











Diagnostic Interview (CIDI29). Non-depressed participants were included with BDI 
scores < 9 and if MDD assessed with the CIDI could not be classified. Depressed and non- 
depressed participants were excluded from participation in the case of: current or recent 
(<2 years) episodes of psychotic or bipolar disorder according to CIDI assessment; visual 
or hearing impairments; pregnancy; and somatic disorders or medication use influencing 
the HPA-axes or the autonomic nervous system. Informed consent of the participants was 
obtained after the nature of the procedures had been fully explained. The research protocol 
was approved by the Medical Ethical Committee of the UMCG. The authors assert that all 
procedures contributing to this work comply with the ethical standards of the relevant 
national and institutional committees on human research and with the Helsinki 
Declaration of 1975, as revised in 2008.
When interested in participating, individuals were supplied with information 
about the study, a written consent form, the BDI questionnaire, the Munich Chronotype 
Questionnaire (MCTQ15), and a health questionnaire. If BDI criteria were met, individuals 
were invited for an appointment to assess the CIDI. If individuals appeared eligible for 
participation, the second part of the appointment was used to clarify the study procedure. 
Procedure
The first two days following the appointment were used to familiarize participants with 
the procedure for the following month. Participants complied to assess themselves 3 times 
a day for 30 consecutive days. Times of assessment were fixed every 6 hours, and were 
based on the participants’ chronotypes as assessed with the MCTQ. Assessments took place 
around 10:00 AM, 4:00 PM, and 10:00 PM for most of the participants. The PsyMate®, an 
electronic device, was used for diary assessments. The diary questions were about affect, 
sleep, activities, and cognitions. Thirty minutes prior to every assessment the PsyMate® 
produced a warning sound and message to stop food and drink intake (besides water), 
smoking, and brushing teeth until the assessment was completed. This was generated to 
prevent interference with the saliva collection. The warning sound was produced again at 
the fixed time point, when participants had to complete the assessment. Completion of the 
assessment could be delayed with a maximum of 1hr in case of unexpected circumstances 
(e.g. appointment or work meeting). The assessment started with the message to start 
saliva collection by keeping a synthetic swab (Salivette®) in the mouth for at least 3 
minutes while completing the assessment. During the clarification of the study procedure 
participants were instructed not to chew the Salivette®, and to store the Salivette® in their 
refrigerator immediately after, or in any case within 4 hours after saliva collection. The 
assessment contained several check-up questions to control whether participants complied 
with the 30-min restrictions of food- and drink intake, smoking, and brushing their teeth. 
Participants were provided with a logbook to note abnormalities and/or protocol violations 
every day. Salivettes® were collected weekly by researchers and centrifuged the same day 
at the special chemistry lab (Laboratory Medicine, UMCG) before they were stored at -80°C 













The Salivettes® of the first 15 depressed and 15 pair-matched non-depressed participants 
were assayed in the chemistry lab of Laboraty Medicine (UMCG). All samples of one 
participant were assayed in the same batch with liquid chromatography-tandem mass 
spectrometry (LC-MS/MS), by means of online-solid phase extraction in combination 
with isotope dilation. LC-MS/MS is known to be analytically compatible and to perform 
well30. The quantification limit for melatonin was 5.0 pmol/L. Mean intra- and inter-assay 
coefficients of variation were below 9.0%. 
Diary data
Positive affect (PA), negative affect (NA) as operationalized by Bylsma31 and fatigue were 
assessed 3 times a day. The positive and negative affect scale both consisted of the mean 
score on 7 items (PA: talkative, enthusiastic, confident, cheerful, energetic, satisfied, and 
happy; NA: tense, anxious, distracted, restless, irritated, depressed, and guilty). All items 
were scored on a Likert scale from 1 ‘not’ up to 7 ‘very’. The PA and NA scales have high 
internal consistency based on person-level reliability estimates in an earlier study (both 
> .90 in31). The mean Cronbach’s alpha coefficient was .86 for PA, and .67 for NA. Fatigue 
was assessed with one item during every assessment, and also scored on a Likert scale from 
1 ‘not’ up to 7 ‘very’. A single-item measurement of fatigue has been used before and showed 
to be a valid measurement to monitor daily fatigue32. 
Predictors of individual-level differences in the role of melatonin
Baseline and diary data of depression severity and perceived sleep were used to assess 
if and how individual-level differences in the role of melatonin in the network models 
(described below) could be explained by differences in depression- and sleep-related 
variables. Subjective sleep quality was assessed at baseline with the item ‘I grade my night’s 
rest’ from 1 ‘bad’ up to 10 ‘excellent’ by means of the MCTQ. Subjective sleep quality and 
duration were monitored at every assessment during the diary study as well, with the item 
‘Did you sleep well?’ with response categories ranging from 1 ‘not well’ to 7 ‘very well’, and 
the item ‘How long did you sleep?’ with response categories ‘<30 minutes’; ‘1/2-1 hour’; 
‘1-2 hours’; ‘2-4 hours’; ‘4-6 hours’; ‘6-7 hours’; ‘7-8 hours’; ‘8-9 hours’; ‘9-10 hours’; 
’10-11 hours’; ’11-12 hours’; ‘> 12 hours’. We used the mean squared successive difference 
(MSSD) as a measure of moment-to-moment stability, and calculated the average MSSD 
over the 90 sleep duration measurements for each participant. High MSSD scores 
represent instability, and low MSSD scores represent stability. Time spent outside was 
measured at baseline with the MCTQ item ‘On average how much time do you spent 
outside every day (by daylight, not under a roof)?’ answered in amount of hours and 
minutes. Weekly exercise at baseline was assessed as ‘If you add all exercise during the week, 
on average how many time do you spend on exercise every week?’ answered in amount 
 of minutes. Daily exercise during the diary study was assessed with an accelerometer. 
Caffeine intake was assessed with a question at baseline: ‘Do you drink coffee or other 
caffeine-containing drinks and if yes, how many cups/cans per day?’. Depression score 











participants used medication, and if yes, what type of medication and what dosage. 
Data Analysis Plan
The average amount of missing melatonin data was 5.4% for the depressed participants 
and 8.2% for the controls. Depressed participants had on average 7.1% missing diary data 
and controls 7.2% missing diary data. We imputed missing data per participant by means 
of the multiple imputation approach Amelia II, available as R package33. With Amelia II it 
is possible to take the dynamic structure of a dataset into account. Fifty imputations were 
estimated for every dataset, and we used the average as the final value that was imputed in 
the original dataset. One depressed participant had to be excluded from analyses because 
of highly collinear variables. The final sample thus consisted of 14 depressed and 15 non- 
depressed participants.  
The moment-to-moment interplay among melatonin, affect, and fatigue 
The moment-to-moment interplay among melatonin, PA, NA, and fatigue was estimated 
by means of GIMME26, which is implemented in MATLAB® (Mathworks, r2014a) and 
LISREL34. GIMME was used to specify unified structural equation models, which explain 
the covariation among variables using lagged (at the next measurement occasion) and 
contemporaneous (at the same measurement occasion) directed relations, at the group- 
and the individual level in an iterative approach35. First, connections among melatonin, 
PA, NA, and fatigue at the level of the group were freed if they significantly improved 
model fit based on Lagrange Multiplier equivalents36 for at least 75% of the sample. Second, 
the estimated group model was optimized by dropping connections that were no longer 
significant for > 75% of the group because of other freed connections. Third, models were 
estimated at the level of the individual, starting by freeing the connections that were 
significant in the group model. Then again, connections that significantly improved model 
fit based on Lagrange Multiplier equivalents were freed for each individual. Fourth, 
freed connections that were no longer significant were dropped from the individual’s 
model, and a confirmatory model was fit. Fit indices were checked after optimal model 
identification. Minimal requirements were RMSEA ≤ .05, SRMR ≤ .05, CFI ≥ .95, and NNFI 
≥ .95 (RMSEA = Root Mean Square Error of Approximation; SRMR = Standardized Root 
Mean Square Residual; CFI = Comparative Fit Index; NNFI = Non-Normed Fit Index). Two 
out of four requirements should be met37. Sleep could not be included in the GIMME model 
estimation. The reason is that the measurement of sleep did not align with the 
measurement of the other study variables, as sleep only occurred once – not thrice – a day. 
We therefore decided to incorporate the sleep measures in the group-level comparison in 
order to test possible associations with sleep. 
Predictors of individual-level differences in the role of melatonin
Independent t-tests or Chi-square tests were performed with IBM SPSS Statistics 22 (IBM, 
SPSS Inc., Chicago, IL) to compare participants that showed associations of melatonin with 
PA, NA, or fatigue in their final models with participants that did not show associations of 
melatonin with the other variables in their final models, to find out whether interindividual 











and sleep quality at baseline and during the diary study, time spent outside measured at 
baseline, weekly exercise at baseline and daily exercise during the diary study, amount of 
daily caffeine at baseline, depression score at baseline, and medication use at baseline. The 
significance level was p<.05.    
Results
Descriptive statistics
In total 15 healthy controls and 14 pair-matched depressed patients were included in 
the analyses. Participants were on average 36 years old (SD = 9), and 76% of the sample 
was female, reflecting the gender difference in depression. The groups did not show 
differences in baseline characteristics except for BDI scores, medication use, and sleep 
quality. BDI scores differed significantly between healthy controls (BDI = 2.2, SD = 3.1) and 
depressed patients (BDI = 30.4, SD = 10.0). Only 20% of non-depressed participants reported 
baseline medication use, in contrast to 64.3% of the depressed participants. The depressed 
participants reported significantly lower sleep quality but not sleep duration (p<.01). More 
details and the means and standard deviations for depressed patients and controls can be 
found in Table 1. 
The moment-to-moment interplay among melatonin, affect, and fatigue 
The final model (containing group- and individual-level relations) showed good fit for all 
individuals, with average fit indices of RMSEA = 0.02, SRMR = 0.06, CFI = 0.99, and NNFI = 
1.00. At the group level, significant contemporaneous associations were found between PA 
and NA (β = -0.47) and between PA and fatigue (β = -0.44). This means that an increase in PA 
was associated with a decrease in NA and fatigue at the same measurement occasion. This 
group-level model with corresponding average β’s is visualized in Figure 1.
Figure 1. Dynamic interplay at the level of the group
No lagged group-level relations were found, therefore only contemporaneous associations estimated 
for all participants are shown; m=melatonin; pa=positive affect; na=negative affect; f=fatigue; beta 











Table 1. Demographic and clinical characteristics
Mean (SD) Total (N=29) Controls (N=15) Depressed (N=14)
Baseline measures
Age, years 35.8 (9.4) 35.1 (8.4) 36.5 (10.6)
Female, n 22 (75.9%) 11 (73.3%) 11 (78.6%)
Smoker, n 5 (17.2%) 3 (20.0%) 2 (14.3%)
BMI, kg/m2 22.9 (3.8) 22.5 (2.7) 23.5 (4.7)
Sleep Quality Working Days, 1-7 6.07 (1.77) 7.27 (0.80) 4.79 (1.63)***
Sleep Quality Free Days, 1-7 6.43 (1.71) 7.47 (0.99) 5.23 (1.59)***
Sleep Duration Working Days, min 451 (79) 453 (57) 450 (99)
Sleep Duration Free Days, min 481 (92) 488 (78) 473 (109)
Time Outside Working Days, min 84 (50) 86 (53) 82 (47)
Time Outside Free Days, min 146 (165) 167 (224) 125 (74)
Weekly Exercise, min 109  (102) 116 (108) 102 (100)
Daily Caffeine Intake 2.43 (2.48) 2.97 (2.57) 1.81 (2.32)
BDI score baseline 15.8 (16.0) 2.2 (3.1) 30.4 (10.0)***
BDI score follow-up 13.0 (14.5) 3.6 (4.3) 23.1 (15.0)***
Medication use, n 12 (41.4%) 3 (20.0%) 9 (64.3%)*
Diary measures
Sleep Quality, 1-7 4.91 (0.96) 5.36 (0.83) 4.44 (0.88)**
Sleep Duration, 1-12 5.83 (0.83) 5.85 (0.58) 5.81 (1.06)
Sleep Stability MSSD 1.69 (2.18) 1.15 (1.08) 2.27 (2.88)
Energy Expenditure, kcal 248 (84) 256 (83) 240 (88)
Note. SD = Standard Deviation of the mean; N = number of participants; BMI = Body Mass Index; 
BDI = Beck Depression Inventory; MSSD = Mean Squared Successive Difference; if not otherwise 
specified, mean and standard deviation (in parentheses) are given; *** p<.05; ** p<.01; * p<.001.
For each individual, 12 possible associations existed between melatonin and affect or 
fatigue. Because of substantial interindividual differences in the presence, strength and 
direction of each of these associations, the associations were not found significant at the 
level of the group. Still, melatonin was associated with affect or fatigue in 83% of individual 
 models, summarized in Figure 2. Momentary increases in melatonin were significantly 
associated with a same-time decrease in PA in 3 participants, a same-time decrease in 
NA in 5 participants, and a same-time increase in fatigue in 5 participants. Next to these 
contemporaneous associations we found that an increase in melatonin predicted a decrease 
 in PA in 6 participants at the next moment (i.e., measurement occasion), a next-moment 











Momentary changes in PA, NA, and fatigue, were associated with same-time changes 
in melatonin in respectively 3, 4, and 5 participants. Again, lagged associations were found 
next to the contemporaneous ones. Changes in PA predicted next-moment changes in 
melatonin in 6 participants, and changes in NA predicted next-moment changes in mela-
tonin in 1 participant. Changes in fatigue predicted changes in melatonin in 4 participants. 
Figure 2. Dynamic interplay among melatonin, affect, and fatigue - a summary of individual models
Thick black lines represent group-level connections; solid lines represent contemporaneous  
connections; dashed lines represent lagged connections; thickness of the coloured lines represents 
the number of individuals with a specific connection.
Predictors of individual-level differences in the role of melatonin
For illustrative purposes, Figure 3 shows a random selection of the final models and 
estimated β-coefficients of 4 participants per melatonin group. We compared 
characteristics of the participants without melatonin associations in their final models 
(n = 5) to participants with melatonin associations in their final models (n = 24). 41.7% of 
participants in the “melatonin group” was depressed, in contrast to 80% of participants 
in the “non-melatonin group” (p=.12). We found that participants without melatonin 
associations reported higher BDI scores at baseline and follow-up compared to participants 
with melatonin associations. Further investigation showed that the depressed patients 
in the group without melatonin assocations showed worse BDI scores than the other 
depressed patients at both baseline (mean 38.5, SD = 12.7 versus mean 27.1, SD = 7.0) and 
follow-up (mean 40.8, SD = 8.0 versus mean  16.0, SD = 10.4). Sleep quality at both working 
and free days as measured at baseline was significantly lower for participants without me-
latonin associations. The match variables age, gender, smoking status, and BMI did not 
differ between melatonin groups. Medication use, sleep duration, time spent outside, 
weekly amount of exercise and daily amount of caffeine did not differ between 
groups either. We found that the average reported sleep quality during the diary 
study was lower in participants without melatonin associations. Sleep duration and stability 
during the diary study did not differ between the groups. Last, energy expenditure 
during the diary study was significantly lower in the participant group with no 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































Participants without melatonin associations were mostly depressed patients (4 out of 
5). We checked baseline characteristics of the participants in this subgroup to see whether 
they were characterized by salient features, and this revealed that the healthy control in 
this group was a frequent cannabis user, reporting cannabis use at least twice a week (i.e., 
over 100 times a year), next to the daily consumption of on average 17 cigarettes. No other 
characteristic aspects could be found. 
Discussion
The application of GIMME to the diaries of participants with and without depression and 
sleep disturbances revealed dynamic associations between endogenous melatonin levels, 
affect, and fatigue. At the level of the group (i.e., for >75% of the sample), PA was associated 
with NA and with fatigue, while there were no associations with melatonin. However, 
melatonin was found to be differentially associated with affect or fatigue in 83% of 
individual-level models. These results underline the importance of GIMME, as it detected 
heterogeneity in melatonin relations as well as affective patterns common to all 
participants. 
The finding that endogenous melatonin secretion was associated with changes in 
affect and fatigue, such that changes in melatonin secretion, a proxy for dynamics in 
circadian rhythmicity, were associated with changes in affect and fatigue is novel. We also 
found associations the other way around, such that changes in affect and fatigue predicted 
changes in melatonin levels. This set of findings might point towards the presence of a 
feedback loop between psychological and physiological phenomena for some people, and 
not a one-way association in which melatonin fluctuations are responsible for subsequent 
changes in affect and fatigue. Another explanation is that an external unmeasured factor 
was responsible for the associations. Either way, this opens new avenues for research.
The individual final models of five participants did not show associations between 
endogenous melatonin levels and other variables. Some provocative characteristics were 
found between the “non-melatonin group” and the “melatonin group” in spite of the small 
group size of the “non-melatonin group” (N=5). The majority of these participants were 
suffering from MDD (n = 4), and the healthy control was a frequent cannabis user. It was 
recently shown that chronic marijuana use is associated with a more robust synchrony of 
the circadian rhythm with the 24-hour cycle compared to non-users38. This synchronizing 
effect of marijuana might have overruled the effect of melatonin, and therefore be 
responsible for a disconnection between melatonin secretion and its psychophysiological 
effect. 
The depressed patients in the subgroup without melatonin associations reported the 
highest depression scores of all participants at baseline and at follow-up, suggesting that 
the depression was most severe in this subgroup. Arguably, particularly severe depression 
is associated with circadian rhythm disturbances, although the direction of this association 











could be caused by circadian rhythm disruptions, the disruptions could be an effect of the 
severe depression and corresponding alterations in affect or fatigue, or a feedback loop 
might exist between the two processes. 
Some considerations regarding the analyses should be mentioned. Although sleep 
is known to be associated with affect39, fatigue40, and melatonin secretion10, we did not 
include sleep in the GIMME model estimation. Future studies should measure partici-
pants for a longer time period and with a time interval of one day instead of 6 hours in 
order to incorporate daily fluctuations of sleep within the models. The disadvantage of a 
larger time interval between measurements is that within-day melatonin fluctuations can-
not be detected anymore. A second limitation is the fact that GIMME only included 1 lag. 
Arguably, this could have resulted in loss of information. However, a posteriori model 
validation showed that a lag of 1 is generally sufficient when the measurement occasions 
are relatively infrequent, as in hours versus seconds41. Besides, the half-life of melatonin is 
estimated to be around 30 minutes42, and we argued that recently synthesized melatonin 
will not have an impact on affect or fatigue ≥2 lags after secretion. A third difficulty with 
regard to the present study is that the contemporaneous associations estimated by means 
of GIMME are pointed in a direction. The directed contemporaneous relations may not 
be intuitive, because the measurement of the parameters between which a direction was 
estimated occurred at the same point in time. Statistically the direction can be interpreted 
as a difference in explained variance between the parameters. The advanced GIMME-MS 
was recently developed to verify the direction of these contemporaneous relationships. The 
utilization of GIMME-MS to verify these associations is a key area of future work in this 
perspective. This point and how to interpret GIMME in clinical data was further elaborated 
on in a recent publication of Beltz et al.43. 
Our study holds some implications for future research. We found that participants 
in whom melatonin was not associated with affect or fatigue showed some remarkable 
characteristics such as severe depression scores. It would be of particular interest to 
figure out what mechanisms might be responsible for these characteristics. We believe this 
group is definitely interesting to give some further attention because this may explain why 
melatonin fluctuations are not associated with affect or fatigue and what implications this 
has for depression course in these participants. This study was among the first in which 
the potential GIMME analyses for repeated psychophysiological diary data were shown, 
opening up new area for research. Moreover, the present study holds some content- 
related implications about the dynamics of melatonin with behavioral data. Significant 
heterogeneity existed in the contributions of melatonin to depression-related sleep, and 
it was the marriage of the unique time-series data and GIMME’s combined sample- and 
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The exact nature of the complex relationship between sleep and affect has remained 
unclear. This study investigated the temporal order of change in sleep and affect in 
participants with and without depression. 
27 depressed patients and 27 pair-matched healthy controls assessed their sleep in the 
morning and their affect 3 times a day for 30 consecutive days in their natural environment. 
Daily sleep quality and average positive affect (PA) and negative affect (NA) were used to 
examine whether changes in sleep quality preceded or followed changes in PA and NA, 
and whether this was different for patients and healthy controls. Second, presumptive 
mediating factors were investigated. We hypothesized that fatigue mediated the effect of 
changes in sleep quality on subsequent PA/NA, and that rumination mediated the effect of 
changes in PA/NA on subsequent sleep quality. 
Multilevel models showed that changes in sleep quality predicted changes in PA 
(B=0.08, p<.001) and NA (B=-0.06, p<.001), but not the other way around (PA: B=0.03, p=.70, 
NA: B=-0.05, p=.60). Fatigue was found to be a significant mediator of the relationship 
between sleep quality and PA (Indirect Effect=0.03, p<.001), and between sleep quality 
and NA (Indirect Effect=-0.02, p=.01). Rumination was not investigated because of non- 
significant associations between PA/NA and sleep quality. The associations were not 
different for patients and controls. The analyses were restricted to self-reported sleep 
quality, and conclusions about causality could not be drawn. 
Improvements in sleep quality predicted improvements in affect the following day, 
partly mediated by fatigue. Treatment of sleep symptoms would benefit affect in clinical 
care and beyond.  
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It is well known that sleep and affect are related1-3. A disturbance of positive and negative 
affect is one of the core symptoms of a major depressive disorder (MDD)4,5. The 
disturbance of sleep is also one of the symptoms of a diagnosis of MDD; approximately 70% 
of depressed patients report changes in sleep6,7. The relationship between sleep and affect 
in depression is complex. Depression can be related to difficulty initiating or maintaining 
 sleep (=insomnia), but sometimes also to sleeping too much (=hypersomnia), or both7. 
Similarly, interventions are targeted at increasing sleep time, but also at the opposite (i.e., 
sleep deprivation), even in patients who have insomnia. Sleep deprivation seems to have 
a positive effect on affect in some patients with depression, although the effect does not 
last long8,9. In sum, although there is consensus in the literature that sleep and affect are 
associated with each other, the exact nature of the association remains unclear3,10-13. 
Along with sleep disturbances comes increased fatigue, which can be part of an MDD 
diagnosis as well (Diagnostic and Statistical Manual of Mental Disorders5). Decreased 
subjective sleep quality14 and decreased subjective sleep duration3 have been found to 
be highly correlated with same-time fatigue. Feelings of fatigue have been found to be 
associated with same-time  positive and negative affect12. Based on these findings it may 
be argued that fatigue mediates the temporal association between sleep and subsequent 
affect. However, in these previous studies there was no temporal separation between 
mediator and outcome, and no multilevel approach was used. The association in the 
opposite direction, from affect to subsequent sleep, may be mediated by rumination. 
In a recent review12 it was shown that rumination had a significant impact on sleep 
quality. Next to that, rumination has been found to mediate the relationship between 
negative affect and sleep quality in healthy adults15. In the latter study there were two 
months between assessment of predictor versus mediator and outcome, and besides that 
there was again no temporal separation between mediator and outcome. 
Sleep and affect can both change on a daily basis4,14. These day-to-day changes can 
be captured by the use of multiple repeated assessments (i.e., daily diary study), and such 
a design enables the examination of the temporal order of these changes. This temporal 
order of change in sleep and affect has been investigated before in healthy adults and 
children3,10,16, and in two of these studies a bidirectional effect was found between sleep 
and affect. In patients with depression, the one-way association between sleep quality and 
subsequent affect was investigated in only one study, in a design of 6 consecutive days4. 
Neither sleep duration nor sleep quality were associated with subsequent affect in this 
study. Thus, a depressive disorder might moderate the association between sleep and 
affect: the difference in results between the abovementioned studies may be explained by 
depression status. Possibly, depression weakens the temporal association between sleep 
and affect because of reduced emotional reactivity in depressed patients17. This notion 
needs more research, however, because neither of the abovementioned studies examined 
both healthy and depressed persons within one and the same study. Moreover, in the study 
by Peeters4 the relationship between sleep and affect was investigated only unidirectional, 
and only six time points were used for analyses. The examination of the bidirectional 
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association between sleep and affect in depressed patients and healthy controls with 
multiple repeated assessments could reveal whether depression status indeed moderates 
the association between sleep and subsequent affect, and whether it moderates the 
association between affect and subsequent sleep. The design with multiple repeated within-
day assessments is the major strength of our study compared with earlier studies on this 
topic. This approach enabled to investigate how sleep and affect are temporally associated 
with each other within the day, and to study how the proposed mediators fatigue and 
rumination differentially contribute to these within-day associations. In contrast to 
previous studies on this topic, we were able to better separate the proposed mediators from 
the outcome measures in time. An additional benefit of a multiple repeated assessments 
design is the possibility to take heterogeneity among participants into account18. The first 
aim of the present study was to examine the temporal order of change in affect and sleep, 
with depression status as a potential moderator. In case of significant associations between 
sleep and affect, we investigated mediating factors of the significant association. We 
hypothesized that affect during the day predicts sleep quality the subsequent night, and 
that rumination in the evening mediates this association. Further, we hypothesized that 
sleep quality the previous night predicts affect during the day, and that fatigue in the 
morning mediates this association. 
Methods
Design
Data from the Mood and Movement in Daily Life (MOOVD19,20) were used in the present 
study. The MOOVD study was set up to investigate the dynamic relationship between 
physical activity, mood, and essential physiological processes, in patients with 
depression and healthy controls. A replicated single-subject time-series design was used, in 
which pair-matched depressed patients and healthy controls were monitored 3 times a day 
for 30 subsequent days within their natural environment. Participants filled out electronic 
diaries, wore an accelerometer, and sampled saliva at each assessment point, resulting in 
time series of up to 90 repeated measurements per individual. 
Subjects and procedure
The MOOVD study was conducted from January 2012 until May 2014 in the Northern part 
of the Netherlands. In total, 27 patients with depression and 27 healthy controls completed 
the study. To obtain comparable groups and simplify pair-wise comparison, participants of 
both groups were pair-matched based on gender, age, smoking status and body mass index. 
Recruitment of the depressed patients occurred in the patient population of the University 
Center of Psychiatry (UCP), University Medical Center Groningen (UMCG), Center for 
Integrative Psychiatry (CIP, Lentis), and Dimence Deventer. Healthy controls were 
recruited from the general population by means of advertising in public places. Inclusion 
 criteria for depressed patients were a Beck Depression Inventory (BDI21 score > 14 and 
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current or recent (< 2 months) presence of a DSM-IV major depressive disorder (MDD), 
and for the healthy controls a BDI score < 9 and the absence of MDD, assessed by means 
of the Composite International Diagnostic Interview (CIDI22). Exclusion criteria for all 
participants were: episodes of psychotic or bipolar disorder (current or recent: < 2 years), 
assessed by means of the CIDI; visual or hearing impairments; pregnancy; somatic 
disorder or medication use that severely affects HPA axis or the autonomic nervous system. 
The Medical Ethical Committee of the University Medical Center Groningen approved the 
study protocol. The authors assert that all procedures contributing to this work comply with 
the ethical standards of the relevant national and institutional committees on human 
research and with the Helsinki Declaration as revised in 1989.
Interested individuals received information about the study, a written consent form, 
BDI questionnaire, Munich Chronotype Questionnaire23, and a health questionnaire. 
Eligibility was based on the health information and BDI. If eligible, the individual was 
invited for an appointment during which the CIDI was assessed. The second part of the 
appointment concerned clarification of the study protocol.
The first two days of the study served to get familiar with the protocol for the following 
30 days. Participants were asked to assess themselves 3 times daily. Assessment times were 
fixed with intervals of 6 hours in between, and adjusted to the chronotype of the participant 
as estimated with the Munich Chronotype Questionnaire. This resulted in person-fit times 
of measurement to not interfere with their daily businesses. On average, the assessments 
took place during the late morning (≈10:00 AM), afternoon (≈4:00 PM), and evening (≈10:00 
PM) for most participants. Measurements of the electronic diaries were facilitated by 
means of the PsyMate®, an electronic device to assess daily behavior (PsyMate BV, 
Maastricht, The Netherlands). The diaries consisted of 60 questions about mood, sleep, 
activities and cognitions. The PsyMate® generated an alarm 30 minutes prior to the time 
filling out the questionnaires, with the message to refrain from food and drink intake 
(except for water), smoking, and brushing teeth until the measurement was completed. 
The alarm was generated again at the time the questionnaire had to be filled out.  In case 
 the alarm was missed, participants had a window of one hour to complete the diary 
questionnaire. After this hour the opportunity to enter the diary was lost and the 
measurement was treated as missing. 
Measurements
Positive and negative affect were used as operationalized by Byslma24,25, who used some 
items from the PANAS and some additional items used successfully in previous experience 
sampling studies. The positive affect (PA) scale consisted of the mean score on seven items 
(talkative, enthusiastic, confident, cheerful, energetic, satisfied, and happy), and so did 
the negative affect (NA) scale (tense, anxious, distracted, restless, irritated, depressed, and 
guilty). All items were rated on a Likert scale ranging from 1 ‘not’ up to 7 ‘very’, therefore high 
scores on PA and NA represented high levels of either positive or negative affect. According 
to25, the PA and NA scale had high internal consistency based on person-level reliability 
estimates (all > .90). In the current study, the mean person-level Cronbach’s alpha for PA 
was .85, and the mean Cronbach’s alpha for NA was .64. The mean Cronbach’s alpha for PA 
was .87 for the depressed and .83 for the non-depressed participants. The mean Cronbach’s 
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alpha for NA was .75 for the depressed and .53 for the non-depressed participants. Average 
daily PA  and NA were calculated from the 3-daily scores on both scales.
Three items of the Pittsburgh Sleep Diary (PghSD26) were used to measure subjective 
sleep experiences: (1) ‘Did you sleep well?’, (2) ‘How long did you sleep?’, (3) ‘Awakened by 
alarm clock/radio, someone whom I asked to wake me, noises, or just woke?’. For the 
present study we used the item about sleep quality ‘Did you sleep well?’, rated on a Likert 
scale ranging from 1 ‘not’ to 7 ‘very’, because recent studies indicate that subjective sleep 
quality reflects sleep experience better than subjective sleep duration11. Subjective sleep 
quality is usually assessed by means of a questionnaire such as the Pittsburgh Sleep Quality 
Index27, which has been validated against polysomnographic data, sleep log data, and 
clinical interviews14, and fits a cross-sectional study design. The use of one item to asses 
daily subjective sleep quality is not uncommon in the sleep field of prospective diary 
studies. For example, validity of the item “How was your sleep quality last night?” was 
examined14, and showed to have sufficient internal consistency (α=.89) and sufficient 
criterion validity compared to the commonly used PSQI. Besides, perceived sleep quality 
was assessed with a 5-point Likert scale in the Consensus Sleep Diary28. The sleep items 
in the present study were completed every time participants indicated they had slept since 
the last measurement, but we used only the morning ratings in this study, which reflect the 
quality of sleep during the past night.  
Fatigue was measured 3-daily with the item ‘I feel tired’, rated on a scale ranging from 
1 ‘not’ to 7 ‘very’. In the present study we only used the morning assessment of fatigue, to 
take into account the order of events (t1 = sleep last night, t2 = fatigue in the morning, t3 = 
mean affect during daytime). A single-item measurement of fatigue has been used before 
and showed to be a valid measurement to monitor daily fatigue29. Rumination was 
measured 3-daily with the item ‘I brood a lot’, rated on a scale ranging from 1‘not’ to 7 ‘very’. 
For this study we only used the evening assessment, to take into account the order of events 
(t1 = mean affect during daytime, t2 = rumination in the evening, t3 = sleep the subsequent 
night). 
Statistical analyses
The temporal relationship between sleep and affect
The temporal relationship between sleep and affect was investigated by means of multilevel 
analyses. We specified four autoregressive multilevel models by means of the Stata 
XTMIXED command in Stata 13 (StataCorp LP, College Station, TX). We first tested whether 
changes in sleep quality (deviations from the individual’s mean sleep quality) assessed in 
the morning could predict changes in either PA or NA during the day, while controlling for 
lagged values of sleep quality (i.e., sleep quality the night before). Next, we tested whether 
changes in either PA or NA during the day (deviations from the individual’s mean PA/NA 
levels) could predict changes in sleep quality the subsequent night. This time, the lagged 
value of PA/NA was incorporated in the model. An interaction term was included in every 
model to test if the relationship differed between depressed and non-depressed individuals. 
A trend in the variables can lead to spurious associations between variables30. 
Therefore, trends were removed from all variables before the analyses by means of ordinary 
least squares regression. In order to distinguish effects within participants from effects 
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between participants, the recommended approach of ‘person-mean centering of the 
predictor variables’ was used by calculating the daily deviation from the participants’ mean 
values31,32. These person-mean centered variables, or within-person deviations, were used 
as predictor. We also allowed the coefficient of the predictors to vary among individuals 
(random slope), to take possible heterogeneity into account. Likelihood-ratio tests were 
used to estimate the significance of the random slopes. In search for factors that could 
account for some of the heterogeneity, we examined whether gender, chronotype (0=early, 
1=late), and psychotropic medication (0=no, 1=yes) moderated the associations of interest 
by including interaction terms to the models in case of significant random slopes. Further, 
a random intercept was included in all models. The 95% range of the effect in the 
population was estimated per model, based on this random variation around the slope31. 
Different error-covariance structures were tested, and the best-fitting model was chosen 
based on the Akaike and Bayesian Information Criteria. P-values < 0.05 were considered 
significant. 
Mediation of the relationship between sleep and affect 
In the case a significant association was observed between predictor and outcome, we 
tested whether this association was mediated by either fatigue or rumination, depending 
on the model. For the estimation of the mediation effects, the ‘lower level mediation with 
random indirect effects’ approach, as suggested by Bauer, Preacher, and Gil33 was used. 
This approach allows estimation of the average effect of the mediator and the 
heterogeneity in the strength of this effect across individuals. With this ‘lower level 
mediation with random effects’ approach, the average indirect effect and variance of 
the indirect effect, as well as the average total effect were estimated. This variance of the 
indirect effect quantifies heterogeneity in the strength of the effect at the level of the 
individual. 
Results
Group-level characteristics of depressed patients and healthy controls
In total 62 participants started the diary study period. Four of these participants dropped 
out before the end of the study was reached. Four other participants completed the study 
period but did not have enough valid measurements (T≥60) with regard to accelerometer 
data or diary observations. These participants were therefore removed from the final 
sample, resulting in 54 participants who completed the study period and had sufficient 
valid measurements. According to responses on the Munich Chronotype Questionnaire, 
sleep quality at baseline was higher in controls than in depressive participants on both free 
and working days. Sleep quality was somewhat lower on working days than on free days in 
both groups. Around 80% of the non-depressed participants was employed or student, in 
contrast to 52% of the depressive participants. Further demographic characteristics of the 
sample are presented in Table 1. 
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Table 1. Demographic and clinical characteristics
Healthy Controls Depressed patients Group-comparison
Mean (SD) (N = 27) (N = 27) Statistical Test
Age, years 34.0 (9.0) 34.7 (9.9) F=0.87, p=.80, η2=.001
Female, n 20 20 χ2=0, p=1.00, phi=0
Smoking, n 6 7 χ2=0, p=1.00, phi=.04
BMI, kg/m2 22.5 (2.6) 24.2 (5.9) F=14.14, p=.17, η2=.04
Partner, n 17 15 χ2=0.22, p=.64, phi=-.11











Sleep Quality baseline MCTQ, 0 ‘low’ – 10 ‘high’
Free days 7.5 (1.0) 5.0 (1.8) F=6.06, p<.001, η2=.45
Working days 7.2 (1.1) 4.4 (1.8) F=5.52, p<.001, η2=.46
CIDI sleep symptoms at baseline
Insomnia, n 0 14 χ2=16.30, p<.001, phi=.59
Hypersomnia, n 0 16 χ2=19.98, p<.001, phi=.65
BDI score
Baseline 2.3 (2.7) 31.3 (10.0) F=41.12, p<.001, η2=.80
Follow-up 2.6 (3.6) 24.1 (14.7) F=32.14, p<.001, η2=.52
Psychotropic medication, n 1 17 χ2=13.42, p<.001, phi=.54
Benzodiazepines, n 0 3
Hypnotics, n 0 0
Antipsychotics, n 0 5
Sleep Quality during study, 1 – 7 5.3 (1.2) 4.4 (1.5) F=2.53, p<.001, η2=.25
Positive Affect during study, 1 – 7 4.6 (1.1) 3.4 (1.3) F=1.39, p<.001, η2=.28
Negative Affect during study, 1 – 7 1.5 (0.6) 3.1 (1.2) F=11.66, p<.001, η2=.52
Note. SD = Standard Deviation of the mean; N = number of participants; effect sizes: η2 was calculated for t-tests, 
phi for 2x2 Chi-Square tests, Cramer’s V for >2x2 Chi-Square tests; BMI = Body  Mass Index; 
education level ‘low’ = primary school/ education, vocational education, preparatory secondary vocational education; 
‘middle’= senior general secondary school, pre-university education; ‘high’ = higher professional education, 
scientific education; MCTQ = Munich Chronotype Questionnaire; CIDI = Composite International Diagnostic Interview; 
BDI = Beck Depression Inventory.
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On average 0.35 out of 30 affect measurements (1.2%) were missing (s.d.=0.81, range 3, for 
both PA and NA). On average 2 out of 30 sleep quality measurements (6.7%) were missing 
(s.d.=3.2, range 18). 
The association between sleep quality and subsequent affect
Model 1a. Do changes in sleep quality predict changes in PA and is this relationship moderated 
by depression? 
The results of all multilevel models are summarized in Table 2. The default covariance- 
structure “independent” provided the best model fit in all multilevel models. The multilevel 
model for PA showed that changes in sleep quality predicted changes in PA (B=0.08, 95% CI 
0.06 to 0.11, p<.001); an improvement in sleep quality predicted a subsequent improvement 
of PA. A significant autoregressive effect of PA was found as well (B=0.14, 95% CI 0.09 to 
0.19, p<.001). This means that an improvement in PA predicted a higher score on PA the next 
day. The relationship was not significantly moderated by depression (B=0.04, 95% CI -0.09 
to 0.01, p=.14), and the moderation term was therefore removed from the model. Significant 
random slopes were found for both sleep quality and lagged PA, indicating that the 
magnitude of the associations differed significantly between individuals. Gender, 
chronotype, and psychotropic medication did not significantly moderate the association 
between sleep quality and PA (B for interaction with gender = 0.004, s.e. = 0.03,  p = .91; B for 
interaction with chronotype = -0.01, s.e. = 0.03, p = .63; B for interaction with psychotropic 
medication = -0.04, s.e. = 0.03 , p = .16). The standard deviation around the sleep quality 
slope was 0.25, corresponding with a variance of 0.06. On the basis of this variance it was 
estimated that 95% of the population has coefficients between -0.41 and 0.57 for the effect 
of sleep quality on PA. 
Model 1b. Do changes in sleep quality predict changes in NA and is this relationship moderated 
by depression?
Changes in sleep quality predicted changes in NA (B=-0.06, 95% CI -0.08 to -0.03, p<.001). 
An improvement in sleep quality predicted a decrease in NA, and here an autoregressive 
effect of NA was observed as well (B=0.26, 95% CI 0.21 to 0.31, p<.001). This indicates that an 
increase in NA predicted more negative affect the subsequent day. Again, the relationship 
was not significantly moderated by depression (B=-0.03, 95% CI -0.08 to 0.02, p=.29). 
Significant random slopes were estimated for both sleep quality and lagged NA. Again, 
gender, chronotype, and psychotropic medication did not significantly moderate the 
association between sleep quality and NA (B for interaction with gender = 0.05, s.e. = 0.03, 
p = .07; B for interaction with chronotype = -0.04, s.e. = 0.03, p = .10; B for interaction with 
psychotropic medication = -0.004, s.e. = 0.03, p = .86). The standard deviation around the 
sleep quality slope was 0.25, corresponding with a variance of 0.06. On the basis of this 
variance, 95% of the population has estimated coefficients between -0.55 and 0.43 for the 
effect of sleep quality on NA. 
In summary, a change in sleep quality was significantly associated with subsequent 
changes in affect in both depressed and non-depressed participants. Figure 1 shows the 
demeaned and detrended associations between sleep quality and PA and NA for every 
participant. 
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Figure 1. Demeaned and detrended associations between sleep quality and PA and NA
Sleep Quality, Positive Affect, and Negative Affect values were demeaned and detrended; dots repre-
sent all values of PA or NA give the value of Sleep Quality; the line represents the linear fit between 
sleep quality and subsequent PA or NA for each participant.
The association between affect and subsequent sleep quality
Model 2a. Do changes in PA predict changes in sleep quality and is this relationship moderated 
by depression? 
We did not find a dynamic effect of PA on sleep quality; changes in PA did not predict 
changes in sleep quality (B=0.03, 95% CI -0.12 to 0.18, p=.70). The autoregressive effect 
of sleep quality was not significant (B=-0.03, 95% CI -0.10 to 0.03, p=.29), and again the 
relationship was not significantly moderated by depression (B=-0.17, 95% CI -0.42 to 0.09, 
p=.21). Once again we found significant random slopes for both PA and lagged sleep quality, 
indicating substantial heterogeneity between individuals. The association between NA and 
sleep quality was not significantly moderated by gender (B for interaction = -0.11, s.e. = 0.13, 
p = .38), chronotype (B for interaction = -0.08, s.e. = 0.13, p = .54), or psychotropic medication 
(B for interaction = -0.25, s.e. = 0.17, p = .14). The standard deviation around the PA slope was 
0.59, corresponding with a variance of 0.35. This gives an estimation of coefficients between 
-1.13 and 1.19 for the effect of PA on sleep quality in 95% of the population.
Model 2b. Do changes in NA predict changes in sleep quality and is this relationship moderated 
by depression?
Similar to Model 2a, changes in NA did not predict changes in sleep quality (B=-0.05, 95% 
CI -0.25 to 0.14, p=.60). Again, the autoregressive effect of sleep quality was not significant 
(B=-0.03, 95% CI -0.09 to 0.03, p=.27), and depression did not significantly moderate the 
associations (B=0.28, 95% CI -0.02 to 0.58, p=.07). A significant random slope was found for 
the lag of sleep quality but not for NA. The 95% population range for the effect of NA on sleep 
quality was therefore not estimated. 
To conclude, changes in affect were not significantly associated with subsequent 
changes in sleep quality. The nonsignificant association between affect and sleep quality 
precluded further investigation of rumination as a mediator of this relationship.
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Fixed Effects     
Intercept 4.04 (0.01) 2.28 (0.01) 4.77 (0.03) 4.77 (0.03)
Sleep Qualityt 0.08 (0.01)*** -0.06 (0.01)***
Sleep Qualityt-1 - - -0.04 (0.03) -0.03 (0.03)
PAt-1 0.14 (0.03)*** - 0.03 (0.08)  -
NAt-1 - 0.26 (0.01)*** - -0.05 (0.10)
Random Effects     






















Residual 0.45 (0.01) 0.39 (0.01) 1.11 (0.03) 1.12 (0.04)
N/observations 54/1451 54/1451 54/1377 54/1377
Note. *** p < 0.01. N.s. = non-significant; N = number of participants. Fixed Effects are estimated 
coefficients (B). Between parentheses: standard error of the observed coefficient (SE). Random 
Effects are standard deviations. Depression x Predictor interaction was not significant and therefore 
removed from the final models.
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Lower level mediation 
Model 3a. Mediation of the temporal relationship between sleep quality and PA by fatigue. 
Results of the lower level mediation analyses are summarized in Table 3. A significant 
mediation effect of fatigue in the association between sleep quality and PA was observed. 
The indirect effect (B=0.03, 95% CI 0.02 to 0.05, p<.001) explained one third of the total 
effect of sleep quality on PA (B=0.09, 95% CI 0.07 to 0.12, p<.001; note that this total effect 
differs slightly from the effect estimated in model 1a; this is due to small differences in 
model specification). Variance of the indirect effect in the population equaled 0.0001. This 
small amount of variance means that the mediation effect was not substantially different 
between individuals. To conclude, the relationship between sleep quality and PA was 
partially mediated by fatigue. An increase in sleep quality resulted in a subsequent decrease 
in fatigue, and a decrease in fatigue resulted in an increase of PA the following day (see 
Figure 2a). 
Model 3b. Mediation of the temporal relationship between sleep quality and NA by fatigue.
Fatigue also significantly mediated the association between sleep quality and NA. The 
indirect effect via fatigue (B=-0.02, 95% CI -0.03 to -0.01, p=.001) explained 33% of the 
total effect (B=-0.06, 95% CI -0.09 to -0.03, p<0.001) of sleep quality on NA. We could hardly 
detect interindividual differences in the indirect effect. The variance of the indirect effect 
equaled 0.00003. To conclude, an increase in sleep quality predicted a decrease in NA, and 
this relationship was partly mediated by fatigue (see Figure 2b). 





Fixed Effects  
 
a -0.28 (0.04)*** -0.28 (0.04)***
b -0.10 (0.02)*** 0.05 (0.01)***
c’ 0.06 (0.01)*** -0.04 (0.01)**
Indirect Effect 0.03 (0.01)*** -0.02 (0.01)**
Total Effect 0.09 (0.01)*** -0.06 (0.01)***
N/observations 54/1451 54/1451
Note. *** p < 0.001, ** p < 0.01. Effects are estimated coefficients (B). Between parentheses: standard 
error of the estimated coefficient (SE). a = effect of sleep quality on fatigue; b = effect of fatigue on 
positive affect; c’ = effect of sleep quality on positive affect; N = number of participants. Random 
effects are not shown, but estimated for all fixed effects.
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Figure 2. Results of the lower level mediation models
Discussion
This study is the first to examine the temporal order of change in sleep quality and affect in 
depressed patients and healthy controls. We found that changes in sleep quality predicted 
changes in PA and NA but not vice versa. The dynamic association between sleep quality 
and PA and between sleep quality and NA was significantly mediated by fatigue. We did 
not find systematic differences between depressed patients and controls, but significant 
heterogeneity was observed among participants within both groups. 
The present results support our hypothesis that changes in sleep quality predict 
changes in positive and negative affect. A change in sleep quality was positively associated 
with a subsequent change in PA, and negatively associated with a subsequent change in 
NA. This is in line with earlier findings16 in a sample of healthy students, in children with 
MDD10, and in healthy adults3. This association was not found in a sample of depressed 
and non-depressed participants who assessed their sleep and affect for one consecutive 
week4. Possibly, an assessment period of one week (i.e., 6 consecutive measurements) was 
too short to find significant associations between variables, as in the current study we did 
find an association between sleep and affect using 30 consecutive measurements. In 
accordance with the abovementioned study4, no differences were found between 
participants with or without depression in the present study. Although depressed patients 
did report lower levels of sleep quality and positive affect and higher negative affect than 
controls in the present study, the associations between these variables were not moderated 
by depression status. This is also in line with findings from another study in which the 
association between retrospectively assessed sleep at baseline and ambulatory assessments 
of positive and negative affect of 3 consecutive days was similar for depressed and healthy 
participants34. Altogether, these findings suggest that the effect of sleep quality on PA and 
NA is similar for depressed and non-depressed people. 
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We found that fatigue was a significant mediator of the relationship between sleep 
quality and our affect measures, congruent with earlier studies which showed that sleep 
quality was associated with increased fatigue12,14. It was previously shown that how tired 
a person feels when waking up is among the most important factors associated with 
judging one’s sleep quality in insomnia patients and healthy persons35. This overlap 
between fatigue and sleep quality could explain (part of) the variance in the estimated 
association between sleep quality, fatigue, and subsequent affect. Contrary to this earlier 
review12, and to earlier ambulatory assessment studies10,16, we did not observe a dynamic 
relationship between PA or NA and subsequent sleep quality, and therefore did not test the 
assumed mediation of the association between affect and sleep quality by rumination15. 
One reason why we did not find a significant temporal relationship between PA/NA 
and subsequent sleep quality in this study may be individual heterogeneity. We found 
significant random slopes indicating substantial differences between individuals in the 
examined temporal relationships. This heterogeneity could not be explained by gender, 
chronotype, or psychotropic medication, however it could be possible that other 
unmeasured factors were responsible for the individual differences. The estimated 
confidence intervals of the random slopes showed the presence of negative as well as 
positive regression coefficients at the individual level. A combination of negative and 
positive coefficients could result in an average group effect of about zero, because opposing 
regression coefficients at the level of the individual cancel each other out. A possible 
explanation for this heterogeneity is that, in contrast to earlier studies that did find 
significant associations between affect and subsequent sleep10,16, our affect measures had 
a pleasure and an activation dimension36. In the present study, an individual could report 
high PA because of being energetic (=high activation, high pleasure), or because of feeling 
relaxed (=low activation, high pleasure). Arguably, an increase in energy influences sleep 
quality negatively because the individual may become restless due to feeling energetic. 
High arousal could be the underlying mechanism that is responsible for this relationship. 
Contrary, an increase in feelings of relaxation may influence subsequent sleep quality 
positively because it relaxes the body due to low activation and high pleasure. In this case, 
low arousal has the opposite impact on sleep behavior. The same argument holds for NA. 
An individual might report high NA because of anxiety (=high activation, low pleasure), 
or because of depression (=low activation, low pleasure). Low activation items were not 
incorporated in the affect measurements of the previous studies10,16, which may explain 
the discrepancy in results compared with our study. 
Some methodological limitations should be kept in mind. The mean Cronbach’s alpha 
of the NA scale was low (.64 for the group and .53 for the non-depressed participants). The 
influence of each item was checked for each individual separately in order to investigate 
whether there was one item that lowered Cronbach’s alpha in the majority of participants. 
Different items were responsible for a low alpha in different participants. No items were 
removed from the NA scale because of these interindividual differences. Quality of sleep 
was assessed with a single self-report item. It could be argued that one item is not sufficient 
to measure sleep quality reliably. Nevertheless, recent studies showed the validity of using 
this item to assess subjective sleep quality14,28. We believe that this measure is at least as 
valuable as more complex and objective sleep assessment methods such as actigraphy 
4
Sleep quality predicts positive an
d n
egative affect but n
ot vice versa
63
registration, because patients report experienced sleep quality in a similar ‘self-report’ 
manner in contact with their therapist. This makes our findings connect closely to the 
reported experiences in clinical practice. The same could be argued about fatigue and 
rumination. A single-item assessment of fatigue was used in an earlier study and shown 
to be a valid measurement to assess daily fatigue14. We could not find studies that used a 
single-item assessment of rumination. The use of a more extensive measurement tool 
to assess rumination would obviously be better. However, this was not an option in the 
present study because questionnaires in diary studies should be as short as possible to keep 
participants motivated. An additional limitation is the partial overlap between morning 
fatigue, evening rumination and the daily affect measurements. One-third of the daily 
affect measurement was confounded with fatigue and rumination, but two-thirds was 
not. Besides, fatigue may be confounded with the sleep measure: both were assessed at the 
same time point, and fatigue is known to be an important factor in judging sleep quality35. 
This could have explained (part of) the variance in the observed associations. Another 
limitation of the observational design that was used in this study is that we could not draw 
conclusions about causality between sleep quality and affect. Future intervention studies 
would be helpful in our understanding of causality between sleep and affect. Still, this is 
the first study in which one of the most important criteria of causality, i.e. the temporal 
order of change between sleep and affect was established in depressed and non-depressed 
participants. The ambulatory assessment design with its many repeated assessments of 
both sleep and affect within individuals made this possible.
Sleep disturbance is among the core symptoms of the diagnosis of major depressive 
disorder. In clinical practice, sleep is often part of the treatment and relapse prevention 
 plan, as impaired sleep is an important risk factor for relapse or recurrence. Still, 
interventions with a focus on sleep are often not mentioned in treatment protocols for 
depression37-39. A positive change in self-reported sleep quality might be the start of a 
virtuous spiral or self-reinforcing cycle in patients: the improved sleep quality might 
improve mood, which then could have a positive impact on the overall functioning of 
the patient, which in turn may improve mood, and so forth. Our results point towards 
the importance of a tailored sleep-oriented treatment in MDD, taking individual 
differences into account to provide the best-fitting treatment. Heterogeneity between 
patients in within-person associations might be uncovered by the use of daily sleep and 
mood diaries. This personalized approach may be a helpful tool because it might give 
insight into the association between sleep and affect for each individual patient. A 
behavior-oriented approach to sleeping problems (e.g., sleep hygiene advice such as: always 
go to bed at same time, sleep in a dark, cool, silent room, avoid alcohol, caffeine, and heavy 
meals before sleeping, practice exercise during day, don’t nap after 4pm, do relaxation 
before sleeping40) or Cognitive Behavioral Therapy for Insomnia (CBT-I) instead of 
prescribing medication may be adopted by the general practitioner as well. This approach 
could be adapted to individual needs based on severity of sleep disturbances assessed 
with sleep diaries, actigraphy information, or an insomnia/hypersomnia questionnaire. 
Treatment of sleep disturbances may not only decrease the sleep disturbances (without 
the risk of side effects or dependence) but could also improve mood and thus prevent 
(non-)depressed patients from ending up in a negative vicious cycle in which poor sleep 
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quality increases negative mood and so forth. 
To conclude, our study showed that changes in sleep quality predicted subsequent 
changes in affect, partly via fatigue, underlining the need for more attention to sleep 
problems in the treatment of depression. Heterogeneity in the strength and sign of the 
observed associations suggests substantial interindividual differences, which calls for a 
personalized approach.  
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Epidemiological studies have shown an association between physical activity and sleep, 
but it is unclear what the temporal order of this association is and whether it differs for 
depressed patients and healthy controls. Using a multiple repeated observations design, 27 
depressed and 27 pair-matched nondepressed participants completed daily measurements 
of subjective sleep quality and duration during 30 consecutive days while an accelerometer 
continuously registered their physical activity. Changes in sleep duration, not quality, 
predicted next-day changes in physical activity (B=-0.21, p<.001), but not the other way 
around. Significant heterogeneity between individuals was observed, but the effect was not 
different for depressed and nondepressed participants. The findings underline the strength 
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Introduction
Physical activity and sleep play an important role in the etiology, maintenance, and 
treatment of major depression1,2. The amount of physical activity and sleep can influence 
each other, although this bidirectional relationship is not fully understood1,3. To clarify this 
relationship and its role in depression, it is important to further investigate the relationship 
between physical activity and sleep in depressed and nondepressed people. Since sleep 
and physical activity are both altered in major depressive disorder4-6, it would be valuable 
to investigate if and in what order they affect each other in daily life. To the best of our 
knowledge, this was not investigated before in depressed patients.  
Every opportunity to improve the treatment of depression should be seized, because 
treatment is not always sufficient, while the recurrence rate of depression increases with 
every new episode7. Healthcare professionals in the Netherlands use a multidisciplinary 
guideline for the treatment of depression8. Though sleep is seen as an important factor 
in depression, interventions concerning the improvement of sleep are not included nor 
mentioned in the treatment guidelines and protocols for depression8,9. In contrast, advice 
with regard to physical activity is commonly accepted in the treatment (and prevention) 
of depression and is included as a basic intervention in the multidisciplinary guideline. A 
better understanding of the bidirectional relationship between sleep and activity in 
depressed patients could be used as a first incentive to improve depression treatment 
linked to activity or sleep.
The effect of exercise interventions on sleep has been investigated in depressed 
patients. Adults with depression and adults with chronic sleep complaints experienced 
a positive impact of exercise programs on subjective sleep quality, which also led to a 
decrease of depressive symptoms10-13. An improved subjective quality and duration of 
sleep ameliorated mood in both depressed and nondepressed people14,15. We could not find 
studies that investigate the influence of sleep on physical activity in depressed people. In 
intervention studies with healthy people and people with sleep complaints, improved sleep 
quality and duration were associated with an increase in physical activity12,13,16-19.  
The relationship between sleep and physical activity has been investigated mostly 
by means of intervention studies, as the above paragraph shows. An alternative approach 
to investigate the relationship between sleep and activity is by using multiple repeated 
observations in daily life. One diary study examined whether the amount of exercise 
predicted changes in subsequent sleep self-reports and vice versa, in a sample of 79 older 
adults with a sedentary lifestyle during a lifestyle intervention study20. An increase in 
exercise during the day was found to predict an increase in sleep quality, and vice versa. 
Strenous exercise such as running, hockey or squash, and moderate exercise such as 
tennis, volleyball, or badminton, but not the amount of regular physical activity, was used 
as a predictor in this study. To the best of our knowledge, no observational studies with 
repeated measurements were done yet to investigate the temporal dynamics between 
sleep and regular physical activity in adult depressed and nondepressed participants. 
Observational studies with multiple repeated measurements have high ecological validity 
because the observations are a better representation of the daily life of the participant21. 
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Studies with multiple repeated observations can give information about the short-term 
dynamics (from day to day) between physical activity and sleep. Besides, they allow to 
estimate group-level effects while taking into account interindividual heterogeneity. The 
use of multiple repeated observations therefore provides the appropriate design to get a 
closer look at the bidirectional relationship between activity and sleep in the heterogeneous 
population of depressed patients22. 
The aim of the current study is to assess the bidirectional relationship between 
physical activity and subjective quality and duration of sleep in the daily life of depressed 
and nondepressed people. Using multiple repeated observations within depressed and 
matched nondepressed people, we were able to investigate the temporal order of this 
relationship and to disaggregate effects between and within subjects. We expected a 
bidirectional relationship, meaning that subjective sleep measures influence subsequent 
physical activity and vice versa. Second, we wanted to find out whether the relationship is 
different for depressed and nondepressed people. Lack of earlier studies prevented us from 
forming a well-argued hypothesis on this research aim. 
Methods 
We used data from the MOOVD (Mood and Movement in Daily Life) study, a longitudinal 
time-series design in which participants were monitored 3 times a day for 30 consecutive 
days in their natural environment23. Depressed (N=27) and non-depressed participants 
(N=27) were included and pair-matched based on gender, age, smoking, and body mass 
index (BMI). 
Participants 
Participants were recruited between January 2012 and May 2014. Depressed individuals 
were recruited from three outpatient centers for psychiatry; nondepressed individuals 
were recruited from the general population in the Netherlands. Interested people aged 20 
to 50, who could wear an accelerometer for 30 days and could complete a questionnaire 
on an electronic diary three times a day while collecting saliva samples, were informed 
with written information. In the first part of the screening procedure, three self-report 
questionnaires were assessed: (a) a health questionnaire with questions about health 
complaints, sleep, amount of weekly exercise, medication use, and substance (ab)use; 
(b) the Munich Chronotype Questionnaire (MCTQ)24 to assess the sleep-wake rhythm of 
the participant; (c) the Beck Depression Inventory-II (BDI-II)25 to assess the severity of 
depression symptoms in the past 7 days. A BDI-II score ≤ 9 for the controls and ≥ 14 for 
the depressed participants was sufficient to get invited for the second screening part. In 
the second part of the screening, the Composite International Diagnostic Interview26 was 
administered to investigate the absence or presence of a diagnosis of depression according 
to the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; DSM-IV; 
American Psychiatric Association, 2000) Depressed and nondepressed participants were 
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interviewed by a trained researcher using the CIDI, who specifically paid attention to the 
sections on major depressive disorder, bipolar disorder, and psychotic disorder. Depressed 
participants had to suffer from a major depression episode at the time of the interview or 
within two months prior to the interview. Nondepressed participants were excluded if they 
had a current or recent (< 2 months) depressive episode. Somatic disorders or medication 
use influencing the HPA-axis or the autonomic nervous system, severe visual or auditory 
difficulties, pregnancy, and a bipolar or psychotic disorder in the past 2 years were 
additional exclusion criteria. All participants gave written informed consent prior to the 
screening procedure.  
Design
Participants started the thrice-daily assessments immediately following the screening 
interview. The first two days were designed for participants to get used to the electronic 
device and the procedure, and on the third day the official measurement period of 30 days 
started. Participants filled out the diary questionnaire for 30 days, three times a day, using 
an electronic diary (Psymate®, PsyMate BV, Maastricht, The Netherlands), while collecting 
saliva samples. Further, they wore an accelerometer (Actical®, Respironics, Bend, OR, USA) 
during the whole study period. The timing of the measurements was adjusted to the 
individuals’ sleep-wake schedule to not interfere with the regular rhythm of the participant 
24. Participants were asked to complete the BDI questionnaire again during the follow-up 
meeting at the end of the 30-day diary study. 
Outcome measures
Subjective sleep measurements 
Both sleep measures were obtained during the first diary assessment of each day. 
Subjective quality of sleep was assessed with the item “Did you sleep well?” from the 
Pittsburgh Sleep Diary27, with response categories ranging from 1 (not good) to 7 (very 
well). A similar single item to assess subjective sleep quality was used in a previous study28 
and showed sufficient internal consistency and criterion validity compared to the 
commonly used Pittsburgh Sleep Quality Index. Subjective instead of objective 
measurement of sleep was chosen because there are indications that the subjective negative 
experience of sleep duration can influence mood and behavior, even when the objective 
amount of sleep was sufficient29,30. We expected that this psychological effect would 
influence the amount of physical activity as well. Subjective duration of sleep was measured 
with the item “How long did you sleep?” with 12 response categories, < 30 min; ½ - 1 hr; 1 – 2 
hr; 2 – 4 hr; 4 – 6 hr; 6 – 7 hr; 7 – 8 hr; 8 – 9 hr; 9 – 10 hr; 10 – 11 hr; 11 – 12 hr; > 12 hr. Subjective 
sleep duration was operationalized as a continuous variable with range 1 to 12 representing 
these categories. 
Physical activity
The Actical®, an omnidirectional accelerometer, was worn on the wrist of the nondominant 
hand during the whole measurement period for the objective measurement of physical 
activity. Output of the Actical® was presented as energy expenditure per minute. Energy 
expenditure reflects the amount of kilocalories used for physical activity per kilogram 
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body weight. The obtained value was multiplied with the body weight (in kilogram) of the 
participant, to obtain the amount of kilocalories used for physical activity. Physical activity 
was monitored continuously, but we used only the activity data assessed during the 12 hr 
between the first and last diary assessment of each day for our physical activity 
measure. This prevented overlap between sleep and physical activity measures. The sum 
score of energy expenditure during each day was calculated for each participant, and 
expressed as physical activity31. Research shows that longer-term physical activity has more 
predictive capacity compared with short-term physical activity (e.g. 1 hr of exercise) with 
regard to sleep17,32. It is also shown that physical activity due to exercise appears to be 
compensated by a decrease in physical activity during the remaining part of the same day33. 
This means that the total amount of daily physical activity may stay the same compared 
to nonexercise days. For this reason we used the total amount of physical activity over the 
whole day.
Statistical Analysis
Baseline characteristics were compared between the depressed and nondepressed group 
with an independent samples t-test by means of IBM SPSS Statistics 20 (IBM, SPSS Inc., 
Chicago, IL). We investigated whether changes in physical activity preceded and predicted 
a change in sleep quality or duration, and vice versa, in four separate analyses. We also 
assessed whether this relationship differed between depressed and nondepressed people. 
Four autoregressive multilevel analyses were performed using Stata 13 (StataCorp LP, 
College Station, TX) by means of the XTMIXED command. Every subject of the final sample 
was included in the analyses, regardless the amount of missing data. We checked for 
nonlinearity by means of quadratic predictor terms, and used bootstrapped confidence 
intervals. Bootstrapped confidence intervals do not rely on potentially problematic 
distributional assumptions34. We first tested whether a change in sleep quality (t) last 
night predicted a change in subsequent physical activity (t). The italic t refers to the current 
measurement day, t-1 to the previous day, and so forth. Sleep quality last night was assessed 
in the morning of the day (t), and subsequent physical activity was assessed from that point 
on the same day (t). To take autocorrelation into account, a lagged value of sleep quality, 
that is, sleep quality in the previous night (t-1) was incorporated into the model. Next, the 
reverse relationship was tested to find out whether a change in physical activity the 
previous day (t-1) predicted a change in sleep quality the subsequent night (t). Again, we 
incorporated a lagged value of physical activity (t-1) to estimate the effect of 
autoregression. Similar models were built for sleep duration. In every model an 
interaction term was included to test whether the relationship differed between the 
depressed and nondepressed group. 
A trend in the variables can lead to spurious associations between the variables35. 
Therefore, trends were removed from the variables using ordinary least squares (OLS) 
regression, for each individual separately, before the analyses were performed. In order 
to distinguish effects within participants from effects between participants, the 
recommended approach of “person-mean centering of the predictor variables” was used by 
calculating the daily deviation from the participants’ mean values for the predictors36,37. 
As a result the mean value of each predictor equaled zero for all participants, canceling out 
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all between-subject differences in levels. Consequently, the regression coefficients could be 
interpreted as within-subjects effects. We also allowed the coefficient of these predictors 
to vary among individuals (random slope), to take into account possible heterogeneity of 
the effects among participants. Significance of random slopes was estimated by means of 
likelihood-ratio tests. When significant random slopes were found, we predicted the 
effect per individual based on Best Linear Unbiased Prediction38. The individual effects 
were then visualized with a histogram. Further, a random intercept was included in all 
models. Various covariance structures were tested for the random effects and the residuals. 
The best-fitting model was chosen based on Akaike and Bayesian Information Criteria. In 
most models, the best-fitting covariance structure for the random effects and for the 
residuals was independent. 
The season and day of the week were included in the models as covariates, because 
they are seen as a factor of influence on sleep quality and the amount of physical 
activity39-41. The dates at which participants monitored themselves were classified based 
on the astronomical seasons spring, summer, autumn, and winter (winter used as 
reference category), and as the respective weekdays (Sunday used as a reference category). 
Sensitivity analysis
A sensitivity analysis was performed to examine whether low levels of physical activity 
may have been responsible for some of the results. Therefore, the four autoregressive 
multilevel analyses were repeated in the subsample of participants whose energy 
expenditure was higher than the average (≥ 756 kcal per day). 
Results
Baseline statistics
The study period of 30 days was started by 62 participants. Four participants dropped out 
before the end of the study. Another four participants completed the study but did not have 
enough valid measurements (T<60) with regard to physical activity or diary observations, 
and were therefore removed from the final sample. Most of the remaining 54 participants 
were matched based on gender, age, smoking, and BMI (N=50). Four participants could 
not be matched. Table 1 summarizes the baseline characteristics for both groups. 
Depressed participants reported a significantly lower quality of sleep on working days 
compared with the nondepressed participants as measured with the MCTQ, t (42) = 6.79, 
95% CI of the difference 2.0 to 3.6, p < 0.01. During days off, the depressed group also 
scored significantly lower on sleep quality compared with the nondepressed group, t (40) 
= 6.40, 95% CI of the difference 1.8 to 3.4, p < 0.01. Sleep duration on days off reported at 
baseline was significantly shorter for depressed participants compared with nondepressed 
participants (t (50) = 2.10, 95% CI of the difference 2 to 91, p = 0.04). At working days, no 
difference was found between the groups. 
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Table 1. Demographic and clinical characteristics of MOOVD participants
Depressed (N=27) Non-depressed 
(N=27)
Age, years (sd) 34.7 (9.9) 34.0 (9.0)
Female, n 20 20 
BMI, kg/m2 (sd) 24.2 (6.0) 22.5 (2.6)
Smoker, n 7 6












Baseline measurement 31.3 (10.0)*** 2.3 (2.7)
Follow-up measurement 24.1 (14.7)*** 2.6 (3.6)
Baseline quality night’s rest (MCTQ) score range: 1 ‘lowest’ to 10 ‘highest’, (sd)
Workday 4.4 (1.8)*** 7.2 (1.1)
Free day 5.0 (1.8)*** 7.5 (1.0)
Baseline sleep duration (MCTQ), minutes (sd)
Workday 430 (92) 451 (49)
Free day 450 (95) 497 (63)
Total amount of exercise, mins per week (sd) 103 (95) 144 (150)
Daily physical activity during study period, kilocal (sd) 718 (226)* 793 (234)
Medication use, n 17*** 3
Antidepressants use, n 14*** 1
Note. Education level ‘low’ = primary school/ education, vocational education, preparatory secondary 
vocational education; ‘middle’= senior general secondary school, pre-university education; ‘high’ = 
higher professional education, scientific education; * p < .05; *** p < .001.
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There was no significant difference between the groups in the amount of partici-
pants that played sports at the baseline measurement of the study (p > 0.05).   The 
reported amount of exercise per week at the baseline measurement also did 
not differ between the depressed and the nondepressed participants (p > 0.05). 
Out of the 17 participants with depression that reported medication use, 14 used 
antidepressants. One nondepressed participant reported antidepressant use out of the 
three nondepressed participants that reported medication use.  
Multilevel analyses 
Model 1: do changes in sleep quality precede changes in physical activity? 
The multilevel model for physical activity shows that changes in quality of sleep did not 
precede changes in physical activity (B = 0.03, 95% CI -0.07 to 0.12, p = 0.60; see Table 2, 
Model 1). Participants’ physical activity was not significantly different between seasons. 
Average physical activity was significantly higher on all days compared with Sundays (p < 
0.001). The relationship between sleep quality and physical activity was not significantly 
moderated by depression status (B = -0.16, 95% CI -0.33 to 0.01, p = .06), and therefore this 
interaction term was omitted from the final model. A significant random slope was found 
for sleep quality (sd2 = 0.23, 95% CI 0.13 to 0.41). This indicates that the strength of the effect 
of sleep quality on subsequent physical activity differed substantially between participants. 
Best Linear Unbiased Prediction was used to estimate the predicted individual effects of 
sleep quality on physical activity in Figure 1. 
Figure 1. 
We estimated the size and direction of the effect of sleep quality on subsequent physical activity for 
each individual by means of Best Linear Unbiased Prediction (BLUP). The x-axis represents size and 
direction of these estimated coefficients, with the number of participants on the y-axis. Example 
interpretation of the rightmost bar: for n = 2 individuals the predicted coefficient lies between 0.2 and 
0.3, which suggests that an increase of 1 unit in sleep quality predicted a subsequent increase between 
0.2 and 0.3 unit in physical activity in these individuals.
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Model 2: do changes in sleep duration precede changes in physical activity? 
The multilevel model for physical activity (Table 2, Model 2) shows that changes in sleep 
duration did precede changes in physical activity (B = -0.21, 95% CI -0.31 to -0.12, p < 0.001). 
This means that, when participants slept longer than was typical for them, they were less 
physically active than usual the following day. Average amount of physical activity was 
not different between different seasons (p > 0.05), and significantly lower on Sundays 
compared with all other days of the week (p < 0.001). The relationship between physical 
activity and sleep quality was not significantly moderated by depression (B = 0.03, 95% CI 
-0.15 to 0.21, p = 0.74). A significant random slope was estimated for sleep duration (sd2 = 
0.31, 95% CI 0.22 to 0.45), indicating individual variability in the magnitude of the effect of 
sleep duration on physical activity. The predicted individual effects of sleep duration on 
physical activity were calculated by means of BLUP and visualized in Figure 2. 
Figure 2. 
We estimated the size and direction of the effect of sleep duration on subsequent physical activity for 
each individual by means of Best Linear Unbiased Prediction (BLUP). The x-axis represents size and 
direction of these estimated coefficients, with the number of participants on the y-axis.
Model 3: do changes in physical activity precede changes in sleep quality?
The multilevel model for sleep quality (Table 2, Model 3) shows that changes in physical 
activity did not precede changes in sleep quality (B = -0.001, 95% CI -0.03 to 0.03, p = 0.93). 
Participants’ average sleep quality was not different on different days of the week or 
seasons. The relationship between physical activity and sleep quality did not differ between 
depressed and nondepressed groups (B = -0.03, 95% CI -0.11 to 0.04, p = 0.39). No significant 
random slopes were found, indicating that there did not exist significant variability 
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Fixed Effects    
Intercept 6.58 (0.22) 6.68 (0.24) 4.99 (0.13) 6.03 (0.15)
Physical activityt-1 -0.003 (0.04) 0.004 (0.03) -0.001 (0.02) 0.02 (0.02)
Sleep qualityt 0.03 (0.05)  
Sleep qualityt-1 -0.01 (0.02)
Sleep durationt  -0.21 (0.05)***  
Sleep durationt-1 -0.10 (0.03)***































































Random Effects    














Residual 1.84 (0.06) 1.81 (0.06) 1.13 (0.03) 1.06 (0.04)
N/observations 54/1425 54/1423 54/1353 54/1349
Note. *** p < 0.001, ** p < 0.01, * p < 0.05. N = number of participants. Fixed effects are estimated 
coefficients (B). Values for Physical activityt and Physical activityt-1 are 100 times smaller than 
observed values (rescaled for the sake of clarity). Between parentheses: standard error (SE) of the 
observed coefficient. Random effects are variances. Moderation effects were not significant and 
therefore removed from the final models.
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Model 4: do changes in physical activity precede changes in sleep duration?
The multilevel model for sleep duration (Table 2, Model 4) shows that changes in physical 
activity did not precede changes in sleep duration (B = 0.02, 95% CI -0.01 to 0.05, p = 0.17). 
Average sleep duration was significantly less on Mondays, Tuesdays, Thursdays and Fridays 
compared with Sundays (p < 0.01). The relationship between sleep duration and physical 
activity was not significantly different between the different groups (B = -0.02, 95% CI -0.09 
to 0.04, p = 0.50). No significant random slope was found for the effect of physical activity. A 
significant random slope was found for the autoregressive effect of sleep duration. 
Sensitivity analysis
Eleven depressed and 15 nondepressed participants were included in the sensitivity 
analysis, based on their mean activity levels during the study period. The results of the 
autoregressive multilevel models were similar to those of the analyses performed on the 
complete sample (results not shown). 
Discussion
In this study the bidirectional relationship between physical activity and subjective sleep 
measurements was assessed in depressed and nondepressed participants. The design with 
multiple repeated measurements enabled us to study this relationship at the group level 
while taking heterogeneity of individuals into account. The hypothesis that a bidirectional 
relationship existed was not confirmed, but we found a significant (unidirectional) effect 
of sleep duration on physical activity. The magnitude of the effect of sleep duration on 
physical activity differed significantly among individuals. Depression did not moderate the 
relationship between sleep and physical activity. 
Two methodological limitations should be kept in mind while interpreting these 
findings. The first limitation concerned the operationalization of the subjective sleep 
measurements. Only one variable was used to define sleep quality, and another one was 
used to define sleep duration. Probably, the sleep measures would have been more reliable 
if multiple variables were used to represent both measures. However, the design 
hindered us to use multiple variables, because questionnaires in a diary study should 
be short to keep participants motivated. A second limitation was that subjective but not 
objective sleep measures were used as a reflection of sleep. Objective sleep measures, such 
as polysomnography, are mostly used to monitor sleep in an experimental setting. The 
observational design of the present study prevented the collection of objective sleep 
measures by means of polysomnography. Though subjective sleep measures have been 
reported to give an overestimation of objective sleep problems29, these observations were 
mainly based on studies that used reported sleep over a longer time period (i.e., average 
sleep duration per month). In the current study subjective sleep was assessed every 
morning in contrast to every month. Moreover, we were not interested in absolute but in 
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An increase in sleep duration predicted a significant decrease in physical activity 
the subsequent day in the present study. A negative association was also reported in an 
observational study with children42. This association between sleep duration and next-
day exercise duration was not found in an observational study with insomniac patients43, 
though the association was stronger for patients with shorter sleep duration at baseline in 
that study. This contradiction in results is probably due to differences in samples. In our 
sample, participants showed normal sleep behavior. A possible – but tentative – explanation 
for the counter-intuitive finding that an increase in subjective sleep duration predicted 
a decrease in subsequent physical activity could be the activation of the parasympathetic 
nervous system (PSNS). The PSNS is part of the autonomic nervous system and responsible 
for bodily functions while in rest and while sleeping. Activation of the PSNS results in a 
decreased heart rate, and increased stomach and intestinal activity44. Possibly, the 
subjective experience of longer sleep results in more relaxation the subsequent day, which 
might enhance activation of the PSNS. This may in turn result in a decrease in physical 
activity. Beforehand we expected that a change in sleep quality would influence physical a 
ctivity the subsequent day as well, but it did not. Dzierzewski and colleagues20, who 
included sedentary elderly in their study, did find an association between sleep quality 
and physical activity. In contrast to those in the Dzierzewski study, the participants in the 
present study were not sedentary. This might be an explanation for the absence of an 
effect of sleep quality on subsequent physical activity. We do think that a long-lasting 
improvement of subjective sleep quality may benefit activity levels, but this is not detectable 
with the present design. The long-term effect of sleep quality on exercise is still unexplored, 
and it would therefore be interesting to focus on this in future research45. 
The nonsignificant finding with regard to the effect of physical activity on subsequent 
sleep was also found in the study with insomniac patients43, in whom physical activity did 
not predict changes in sleep duration as well. Contrary to these findings, the earlier diary 
study in older adults showed a bidirectional relationship between sleep quality and exercise 
in a lifestyle intervention study20. This finding might be explained by the nature of the 
sample: sedentary older people were motivated to enhance the amount of exercise for 16 
weeks. This may suggest that physical activity only influences sleep in sedentary people, or 
that not regular daily physical activity, but moderate and heavy exercise influences sleep. 
Exercise was recommended as a treatment to improve sleep in a recent review about the 
reciprocal relationship between exercise and sleep45. Longitudinal intervention studies 
showed an improvement in sleep quality46,47 and duration32 due to physical activity 
interventions (i.e., exercise for several months 3 times a week) in adults with and also 
without insomnia. The suggestion that the effect of physical activity on sleep is long-spun 
instead of short-term19,48, could be an explanation for this discrepancy.
The heterogeneity in the effects of sleep duration on physical activity emphasizes the 
importance of tailor-fit approaches in research, but also in clinical settings. Substantial 
heterogeneity (i.e., significant random effects) was also reported in the earlier mentioned 
Dzierzewski study20 on exercise and sleep in older adults. Interindividual variability might 
explain why treatment based on group averages is ineffective for some, but not all 
individuals. An appropriate statistical technique to focus on individuals next to group 
averages would be vector autoregressive modeling49. This technique allows investigating 
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the bidirectional dynamics between multiple variables within individuals50,51. By means 
of this technique, the dynamics between several sleep measures, physical activity, and 
affect could be estimated simultaneously per individual and give a detailed view of 
processes between variables within subjects. Techniques like this can be used as a starting 
point for treatment strategies in which individual differences are taking into account.   
In the present observational study the bidirectional dynamic relationship between 
sleep and physical activity was investigated in depressed and nondepressed individuals. 
The hypothesis of a bidirectional relationship between sleep and physical activity was not 
confirmed, but duration of sleep was found to have impact on next day’s physical activity 
negatively. The within-subjects repeated measurements design allowed us to establish the 
temporal order of the effect and to show the presence of substantial heterogeneity between 
individuals. This is important, since ultimately depression treatment should target on what 
comes first and on what works for whom.
 5
The tem
poral order of changes in physical activity and subjective sleep
83
References
1. Lopresti AL, Hood SD and Drummond PD. A review of lifestyle factors that contribute to 
important pathways associated with major depression: Diet, sleep and exercise. J Affect Disord 
2013; 148: 12-27. 
2. Schmid SM, Hallschmid M, Jauch-Chara K, et al. Short-term sleep loss decreases physical activity 
under free-living conditions but does not increase food intake under time-deprived laboratory 
conditions in healthy men. Am J Clin Nutr 2009; 90: 1476-1482. 
3. Youngstedt SD. Effects of exercise on sleep. Clin Sports Med 2005; 24: 355-365. 
4. Da Silva MA, Singh-Manoux A, Brunner EJ, et al. Bidirectional association between physical 
activity and symptoms of anxiety and depression: the Whitehall II study. Eur J Epidemiol 2012; 
27: 537-546. 
5. Tsuno N, Besset A and Ritchie K. Sleep and depression. J Clin Psychiatry 2005; 66: 1254-1269. 
6. Wielopolski J, Reich K, Clepce M, et al. Physical activity and energy expenditure during 
depressive episodes of major depression. J Affect Disord 2015; 174: 310-316. 
7. Solomon D, Keller M, Leon A, et al. Multiple recurrences of major depressive disorder. Am J 
Psychiatry 2000; 157: 229-233. 
8. Spijker J, Bockting CLH, Meeuwissen JAC, et al. Multidisciplinaire richtlijn Depressie. Richtlijn 
voor de diagnostiek, behandeling en begeleiding van volwassen patiënten met een depressieve 
stoornis. 
9. Keijsers GPJ, Minnen Av and Hoogduin K. Protocollaire behandelingen voor volwassenen met 
psychische klachten 1. Amsterdam: Amsterdam, 2011. 
10. Singh NA, Clements KM and Fiatarone MA. Sleep, sleep deprivation, and daytime activities - A 
randomized controlled trial of the effect of exercise on sleep. Sleep 1997; 20: 95-101. 
11. Singh NA, Stavrinos TA, Scarbek Y, et al. A randomized controlled trial of high versus low 
intensity weight training versus general practitioner care for clinical depression in older adults. 
Journals of Gerontology Series A-Biological Sciences and Medical Sciences 2005; 60: 768-776. 
12. Gebhart C, Erlacher D and Schredl M. Moderate exercise plus sleep education improves self- 
reported sleep quality, daytime mood, and vitality in adults with chronic sleep complaints: a 
waiting list-controlled trial. Sleep disorders 2011; 2011: e809312. 
13. Rethorst CD, Sunderajan P, Greer TL, et al. Does exercise improve self-reported sleep quality in 
non-remitted major depressive disorder?. Psychol Med 2013; 43: 699-709. 
14. Bower B, Bylsma LM, Morris BH, et al. Poor reported sleep quality predicts low positive affect in 
daily life among healthy and mood-disordered persons. J Sleep Res 2010; 19: 323-332. 
15. de Wild-Hartmann JA, Wichers M, van Bemmel AL, et al. Day-to-day associations between 
subjective sleep and affect in regard to future depression in a female population-based sample. 
British Journal of Psychiatry 2013; 202: 407-412. 
16. Driver HS and Taylor SR. Exercise and sleep. Sleep Medicine Reviews 2000; 4: 387-402. 
17. Youngstedt SD, Perlis ML, O’Brien PM, et al. No association of sleep with total daily physical 
activity in normal sleepers. Physiol Behav 2003; 78: 395-401. 
18. Schmid SM, Hallschmid M, Jauch-Chara K, et al. Short-term sleep loss decreases physical activity 
under free-living conditions but does not increase food intake under time-deprived laboratory 
conditions in healthy men. Am J Clin Nutr 2009; 90: 1476-1482. 
19. Holfeld B and Ruthig JC. A Longitudinal Examination of Sleep Quality and Physical Activity in 
Older Adults. Journal of Applied Gerontology 2014; 33: 791-807. 
20. Dzierzewski JM, Buman MP, Giacobbi PR,Jr., et al. Exercise and sleep in community- 
dwelling older adults: evidence for a reciprocal relationship. J Sleep Res 2014; 23: 61-68. 
5
The tem
poral order of changes in physical activity and subjective sleep
84
21. Trull TJ and Ebner-Priemer UW. Using Experience Sampling Methods/Ecological Momentary 
Assessment (ESM/EMA) in Clinical Assessment and Clinical Research: Introduction to the 
Special Section. Psychol Assess 2009; 21: 457-462. 
22. Lamers F, de Jonge P, Nolen WA, et al. Identifying Depressive Subtypes in a Large Cohort Study: 
Results From the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 2010; 
71: 1582-1589. 
23. Bouwmans MEJ, Bos EH, Booij SH, et al. Intra- and inter-individual variability of longitudinal 
daytime melatonin secretion patterns in depressed and non-depressed individuals. Chronobiol 
Int 2015; 32: 441-446. 
24. Roenneberg T, Kuehnle T, Juda M, et al. Epidemiology of the human circadian clock. Sleep 
Medicine Reviews 2007; 11: 429-438. 
25. Beck AT, Erbaugh J, Ward CH, et al. An Inventory for Measuring Depression. Arch Gen 
Psychiatry 1961; 4: 561-571. 
26. World Health Organization. Composite International Diagnostic Interview, Version 2.0. 
Geneve: Geneve, 1995. 
27. Monk TH, Reynolds CF, Kupfer DJ, et al. The Pittsburgh Sleep Diary. J Sleep Res 1994; 3: 111-120. 
28. Fung CHL, Nguyen M, Moineddin R, et al. Reliability and validity of the Daily Cognitive- 
Communication and Sleep Profile: a new instrument for monitoring sleep, wakefulness and 
daytime function. International Journal of Methods in Psychiatric Research 2014; 23: 217-228. 
29. Lauderdale DS, Knutson KL, Yan LL, et al. Self-Reported and Measured Sleep Duration How 
Similar Are They?. Epidemiology 2008; 19: 838-845. 
30. Regestein QR, Friebely J, Shifren JL, et al. Self-reported sleep in postmenopausal women. 
Menopause-the Journal of the North American Menopause Society 2004; 11: 198-207. 
31. Heil DP. Predicting activity energy expenditure using the Actical (R) activity monitor. Res Q Exerc 
Sport 2006; 77: 64-80. 
32. Youngstedt SD, OConnor PJ and Dishman RK. The effects of acute exercise on sleep: A 
quantitative synthesis. Sleep 1997; 20: 203-214. 
33. Goran MI and Poehlman ET. Endurance Training does Not Enhance Total Energy-Expenditure in 
Healthy Elderly Persons. Am J Physiol 1992; 263: E950-E957. 
34. Neal DJ and Simons JS. Inference in regression models of heavily skewed alcohol use data: A 
comparison of ordinary least squares, generalized linear models, and bootstrap resampling. 
Psychology of Addictive Behaviors 2007; 21: 441-452. 
35. Rovine MJ and Walls TA. Multilevel Autoregressive Modeling of Interindividual Differences in the 
Stability of a Process. In: Walls TA and Schafer JL (eds) Models for Intensive Longitudinal Data. 
New York: New York, 2006. 
36. Bolger N and Laurenceau J. Intensive longitudinal methods: An introduction to diary and 
experience sampling research. New York: New York, 2013. 
37. Curran PJ and Bauer DJ. The Disaggregation of Within-Person and Between-Person Effects in 
Longitudinal Models of Change. Annual Review of Psychology, Vol 62 2011; 62: 583-619. 
38. Rabe-Hesketh S and Skrondal A. Multilevel and longitudinal modeling using stata. second 
edition ed. College Station, Texas: College Station, Texas, 2008. 
39. Levin S, Dubose KD, Bowles H, et al. Women’s physical activity levels: weekday versus weekend. 
Medicine & Science in Sports & Exercise 2003; 35. 
40. Sigmon ST, Schartel JG, Boulard NE, et al. Activity Level, Activity Enjoyment, and Weather 
as Mediators of Physical Health Risks in Seasonal and Nonseasonal Depression. Journal of 
Rational-Emotive and Cognitive-Behavior Therapy 2010; 28: 42-56. 
41. Pereira D and Elfering A. Social Stressors at Work and Sleep During Weekends: The Mediating 
Role of Psychological Detachment. J Occup Health Psychol 2014; 19: 85-95. 
5
The tem
poral order of changes in physical activity and subjective sleep
85
42. Pesonen A, Sjosten NM, Matthews KA, et al. Temporal Associations between Daytime Physical 
Activity and Sleep in Children. Plos One 2011; 6: e22958. 
43. Baron KG, Reid KJ and Zee PC. Exercise to Improve Sleep in Insomnia: Exploration of the 
Bidirectional Effects. Journal of Clinical Sleep Medicine 2013; 9: 819-824. 
44. McCorry LK. Physiology of the autonomic nervous system. Am J Pharm Educ 2007; 71: 78. 
45. Chennaoui M, Arnal PJ, Sauvet F, et al. Sleep and exercise: A reciprocal issue?. Sleep Medicine 
Reviews 2015; 20: 59-72. 
46. Reid KJ, Baron KG, Lu B, et al. Aerobic exercise improves self-reported sleep and quality of life in 
older adults with insomnia. Sleep Med 2010; 11: 934-940. 
47. Passos GS, Poyares D, Santana MG, et al. Effects of moderate aerobic exercise training on 
chronic primary insomnia. Sleep Med 2011; 12: 1018-1027. 
48. Lambiase MJ, Gabriel KP, Kuller LH, et al. Temporal Relationships between Physical Activity and 
Sleep in Older Women. Med Sci Sports Exerc 2013; 45: 2362-2368. 
49. Brandt PT and Williams JT. Multiple Time Series Models. Thousand Oaks: Thousand Oaks, 2007.
50. Hamaker EL. Why researchers should think “within-person”: a paradigmatic rationale. In: 
Anonymous Handbook of research m ethods for studying daily life. New York: New York, 2012, 
p.43. 
51. Rosmalen JGM, Wenting AMG, Roest AM, et al. Revealing Causal Heterogeneity Using Time 
Series Analysis of Ambulatory Assessments: Application to the Association Between Depression 
and Physical Activity After Myocardial Infarction. Psychosom Med 2012; 74: 377-386. 
5
The tem
poral order of changes in physical activity and subjective sleep

Bidirectionality between sleep symptoms 
and core depressive symptoms and their 
long-term course in major depression
Mara E.J. Bouwmans, Henk Jan Conradi, 
Elisabeth H. Bos, Albertine J. Oldehinkel, 
Peter de Jonge







The objective of this study was to investigate the bidirectional dynamic relationship 
between sleep symptoms and core depressive symptoms and to identify subgroups 
differing with respect to their course.
The weekly state of depressive symptoms in depressed primary care patients (N=267) 
was assessed retrospectively every 3 months for 3 consecutive years. The bidirectional 
relationship between sleep and core symptoms was estimated by means of manifest 
Markov modeling. Data-driven subgroups were estimated with parallel processes – latent 
class growth analyses to identify differences in courses of sleep and core symptoms. 
In total, core symptoms were associated with next-week development (odds=1.42, 95% 
CI 1.20 to 1.67, p<.001) and remission of sleep symptoms (odds=0.86, 95% CI 0.75 to 0.99, 
p=.033). Vice versa sleep symptoms were associated with the development (odds=1.26, 95% 
CI 1.05 to 1.50, p=.012) and remission of core symptoms (odds=0.87, 95% CI 0.76 to 0.99, 
p=.038). Three classes with different 3-year courses were derived. In class 1 the likelihood 
that core symptoms remitted was reduced if sleep symptoms were present, and symptoms 
remained present over 3 years. In class 2 symptoms were bidirectionally related, and 
remitted over 3 years. In class 3 symptoms were not associated, and sleep symptoms 
declined less steeply than core depressive symptoms. 
The results suggest that sleep symptoms should be treated alongside core depressive 
symptoms in patients with an a-synchronic decrease of sleep and core symptoms and 












Sleep disturbances are considered as a transdiagnostic condition, because their presence 
has been found to predict the onset of several psychiatric disorders1,2. Sleep disturbances 
can be seen as a key course modifier in the context of major depressive disorder (MDD). 
They are an independent risk factor for MDD3, and they play an important role in the 
maintenance and exacerbation of  the disorder4,5.  Non-depressed people with insomnia 
have a twofold risk to develop depression compared to people without sleep problems6. 
A lifetime history of hypersomnia, insomnia, or both, is significantly related to future 
development of depression7. Besides, insomnia and hypersomnia belong to the symptoms 
of MDD8, and are present in approximately 70% of depressed patients9,10. Further, sleep 
disturbances often remain as a residual symptom in patients in remission6,10-12. Thus, 
sleep disturbances and depression are clearly associated with each other. However, it 
remains unclear how they interact over time within depressed patients.
A limitation of previous studies is that the relationship between sleep disturbances 
and depression over time has been examined mostly in the general population6,12 and 
rarely in clinical populations6. Furthermore, Baglioni and colleagues6 and Skapinakis et 
al.12 examined whether sleep disturbances were a predictor of depressive episodes at least 
12 months later. This long time lag precludes a fine-grained insight into the interaction 
between sleep disturbances and depression over time. Moreover, because sleep 
disturbances can be part of MDD diagnosis13, this approach could have resulted in an 
artificial overlap between the predictor and outcome variable, thereby possibly 
overestimating the predictive effect of sleep disturbances12. In the present study, core 
symptoms of depression (low mood and/or anhedonia) were used instead of depression 
diagnosis as outcome to overcome the latter problem12. 
Overcoming these limitations is needed to develop a better understanding of the 
exact nature of sleep disturbances in recurrent depression. This may provide targets for 
treatment and prevention. Therefore, in the present study, we examined the bidirectional 
relationship between sleep disturbances and core symptoms of depression, in a 
longitudinal study with repeated weekly measurements for three consecutive years in a 
clinical sample of recurrent depressed primary care patients. 
The first aim of this study was to investigate the bidirectional relationship between 
sleep disturbances and core depressive symptoms, i.e. whether the presence of sleep 
symptoms was associated with the appearance and disappearance of core symptoms and 
vice versa, whether the presence of core symptoms was associated with next-moment 
changes in sleep symptoms. It is plausible that the course of sleep symptoms and core 
depressive symptoms over time differs between patients. Therefore, our second aim was 
to construct data-driven subgroups based on the 3-year course of these symptoms. This 
enabled us to investigate whether sleep symptoms and core depressive symptoms were 
associated with each other differently within these groups. Third, we examined whether 










Materials and Methods 
Participants and design
We used data from a randomized-controlled trial (RCT) that was carried out from 
1998 to 2003 in the Northern part of the Netherlands. The RCT aimed to investigate the 
effectiveness of four treatments for primary care patients with a major depressive disorder 
(MDD)14. 
Patients who were currently treated for a major depressive episode by their general 
practitioner, had suffered one or more previous depressive episodes, and were aged 18-70 
were referred by their general practitioner to participate in the study. Referred patients 
were provided with detailed verbal and written information on the study and screened by 
telephone. After that, patients were interviewed by means of the Composite International 
Diagnostic Interview (CIDI)15 by an experienced research assistant, in order to examine 
the presence of a major depressive disorder (MDD). The CIDI has shown good reliability 
and validity16,17. Diagnostic criteria for major depression had to be met at the time of the 
interview (baseline measurement) or in the 3 months prior to the interview for patients 
to be included in the study. Exclusion criteria were: the presence of a psychotic disorder, 
bipolar disorder, dementia, primary alcohol or drug dependence or abuse, pregnancy, and 
receiving treatment for depression in a specialty mental health setting. Of the 397 referred 
patients, 267 met the inclusion criteria. These patients were stratified according to 
antidepressant usage at baseline and randomly assigned to one of the four treatment 
groups: (1) care as usual (CAU); (2) CAU enhanced by a psycho-educational prevention 
program (PEP); (3) psychiatric consultation and PEP (PC + PEP); or (4) cognitive behavioral 
therapy and PEP (CBT + PEP) in ratio 2:3:1:1. The PEP program was developed to enhance 
self-management and self-efficacy by means of psycho-educational techniques in order to 
decrease the chance of depression recurrence. Patients in the PC + PEP program had an 
appointment with one or two psychiatrists prior to the start of the PEP program. The aim 
of the CBT + PEP program was behavioral activation and restructuring of dysfunctional 
cognitions in 10-12 sessions of 45 minutes prior to the PEP program14. Specific sleep- 
focused components were not incorporated in any of the programs. All participants gave 
informed consent prior to inclusion in the study18. The study was approved by the Medical 
Ethics Committee of the University Medical Center Groningen (no: MEC 96/02/028). Please 
note that no differential effects of the four treatments were found in the RCT regarding 
CIDI-based outcome measures14.
Measurements
Symptoms of depression and sleep 
During the study period, in which patients were followed for a maximum of 173 consecutive 
weeks, patients were interviewed by telephone every 3 months with an adapted CIDI 
depression section to assess the weekly presence or absence of all nine DSM-IV symptoms 
of major depression during that period. In order to prevent recall problems the 
interviewers reminded the patients of their symptom state at the time of the previous 









three months earlier persisted or remitted, and how many weeks ago a possible change 
occurred. If a symptom was absent three months earlier, patients were asked whether the 
symptom remained absent or developed, how many weeks ago this change occurred, and if 
it remained present or remitted again. Besides, interviewers were extensively trained and 
supervised each three months during the entire follow-up period of the study. Supervisors 
were trained at the official WHO-CIDI Training and Reference Center (Academic Medical 
Center, Amsterdam). 
The two core symptoms, (1) depressed mood or irritability most of the day, nearly 
every day; and (2) decreased interest or pleasure in most activities most of each day, nearly 
every day, were selected for the analyses. We did not focus on onset or remission of MDD, 
because the criteria for this diagnosis include sleep problems12. To represent the absence 
or presence of the core symptoms of depression, a dichotomous variable was created with 
values 0 = no core symptoms this week, and 1 = one or two core symptoms this week. 
Weekly sleep symptoms were assessed in the same way as the core symptoms, 
i.e. by means of the adapted CIDI depression section every 3 months. Sleep symptoms 
((1) insomnia nearly every day; or (2) hypersomnia nearly every day) were available as 
0 = no sleep symptoms this week, and 1 = one or two sleep symptoms this week. 
Independent insomnia and hypersomnia ratings were not available.   
Statistical analyses
The temporal relationship between sleep symptoms and core depressive symptoms 
Manifest Markov modeling was used to investigate the (bidirectional) temporal 
relationship between sleep symptoms and core depressive symptoms over time. This 
method allows to investigate the chance that a next-week change (=manifest) in core 
depressive symptoms (i.e., onset or decline) is associated with the state (i.e., present or 
absent) of sleep symptoms in the current week19. Contrariwise, we investigated the 
association of the state of core depressive symptoms this week with a manifest in sleep 
symptoms next week. A graphical representation of the Manifest Markov model is 
presented in Figure S1, Supplemental Content. The software Latent GOLD® 5.0 (Statistical 
Innovations Inc, Belmont, MA) was used to search for the a priori defined manifests and 
to perform simultaneous multiple logistic regression analyses to estimate the chance that 
these manifests were significantly associated with the state of the previous weeks’ sleep 
symptoms or previous weeks’ MDD core symptoms. This means that measurement points 
in which no manifests occurred were discarded from analyses. Two continuous covariates 
(start counting at ‘0’ after a change in state occurred) were computed to control for the 
duration of the state of sleep symptoms and core depressive symptoms (i.e., no symptoms 
versus symptoms). A covariate for time was included to account for the possibility that the 
measurements of sleep symptoms and MDD core symptoms were time dependent. Adding 
a constant covariate to the models would not change unique individual patterns over time, 
therefore we could not control for suggested variables such as depression severity at 
baseline. Not everybody participated an equal amount of weeks; the maximum amount 
(=173 weeks) was used for all participants, as full-information estimates could be computed 
with missing data20. Therefore, missing data were not imputed. The best-fitting and 









Bayesian Information Criterion (BIC) and the modified Akaike Information Criterion 
(AIC3) were compared and the model with the smallest values of these information 
criteria was selected. The syntax of the generic final model is added as an Appendix. The 
hypothesis examined was that manifests in both core symptoms and sleep symptoms 
could be explained significantly with the state of previous weeks’ sleep symptoms and core 
depressive symptoms, respectively. 
Sensitivity analysis: the temporal relationship between other depressive symptoms and core 
symptoms 
For sake of comparison we investigated whether the remaining depressive symptoms were 
of similar importance as sleep symptoms with regard to the likelihood of changes in core 
depressive symptoms. Again we used Manifest Markov analyses, this time for each of the 
remaining six symptoms of MDD. The remaining symptoms included (1) significant weight 
loss when not dieting or weight gain (e.g., a change of more than 5% of body weight in a 
month), or decrease or increase in appetite nearly every day; (2) psychomotor agitation or 
retardation nearly every day; (3) fatigue or loss of energy nearly every day; (4) feelings of 
worthlessness or excessive or inappropriate guilt nearly every day; (5) diminished ability 
to think or concentrate, or indecisiveness, nearly every day; and (6) recurrent thoughts of 
death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific 
plan for committing suicide. Again, for each symptom a dichotomous variable was created 
to represent its weekly absence or presence, with 0 = not reported this week, and 1 = 
reported this week. 
Data-driven subgroups of the 3-year course of sleep symptoms and core depressive symptoms
To establish latent classes representing meaningful differences in course over time of 
both sleep disturbances and core depressive symptoms, a parallel processes – latent class 
growth analysis (PP-LCGA) was performed by means of Mplus (Muthén and Muthén, Los 
Angeles, CA). PP-LCGA is a technique that allows to model multiple data-driven processes 
(in this case sleep symptoms and core symptoms) simultaneously22. PP-LCGA results in a 
distribution of the data in an optimal amount of classes, whereby each class represents a 
substantially different group of patients. Patients are allocated to a class based on how well 
their individual course of sleep symptoms and core depressive symptoms over time is alike 
in these classes23.   
We used PP-LCGA to estimate classes for core symptoms and sleep symptoms 
simultaneously. As PP-LCGA is not suitable for dichotomous variables, the proportion of 
the weekly presence of the variable over the past 3 months was computed for respectively 
core symptoms and sleep symptoms (with 0 = ‘not present’, up to 100 = ‘always present’). 
The timespan of 3 months was chosen as the telephonic CIDI was administered every 
3 months. This means that this part of the analyses focuses on the 3-monthly averages 
and not on week-to-week transitions. The best-fitting model with an optimal amount of 
classes was selected based on the Akaike Information Criterion and the Bayesian 
Information Criterion. The Bootstrapped Likelihood Ratio Test (BLRT) as well as the 
Lo-Mendell-Rubin Likelihood Ratio Test (MLR) were used to end up with the best-fitting 









outperformed the k-1 classes’ model24. Additional criteria were taken into account to find 
the best solution: successful convergence (replication of the same output by choosing the 
first two seeds that give the best log likelihood output); a high entropy value (near 1.0); more 
than 1% of total N in one class; and average latent class probabilities for most likely latent 
class membership by latent class (posterior probabilities) near 1.023. 
The PP-LCGA analyses were used to differentiate between latent classes based on the 
course of both symptoms over time. After these classes were estimated, we determined if 
there was a difference between these classes in how sleep and core depressive symptoms 
were associated with each other over time. Therefore we investigated whether the 
estimated classes showed similar or different bidirectionality between sleep and core 
depressive symptoms by means of the Manifest Markov analyses as mentioned above. 
Predictors of data-driven subgroups of the 3-year course of sleep and core depressive symptoms
To conclude, an analysis of variance (ANOVA) or chi-square test was performed with IBM 
SPSS Statistics 22 (IBM, SPSS Inc., Chicago, IL) to compare classes with regard to baseline 
predictors. Tukey’s test and Bonferroni adjusted tests was used for post-hoc comparison 
of significant class differences after ANOVA and Chi-square tests, respectively. Based on 
earlier research on sleeping problems and depression12, treatment, proportion of time that 
antidepressant medication was used during the study period, amount of symptoms at 
baseline as assessed by the CIDI, age, gender, marital status, occupational status (Are you: 
employed (employed or independent entrepreneur) = ‘1’, homemaker = ‘2’, other (student, 
unemployed, retired, or unable to work) = ‘3’), education level (‘What is the highest level 
of education you have completed?’ with answering categories: low (primary school, lower 
vocational education, pre-vocational education, general secondary education) = ‘1’, middle 
(vocational education, senior general secondary education, pre-university education) = 
‘2’, high (higher vocational education, academic education) = ‘3’), depression severity, the 
amount of previous episodes of depression (≤ 3 episodes = ‘0’, > 3 episodes = ‘1’) 25, age of 
first episode, antidepressant use at baseline, and additional use of psychological therapy 
during the study period were used as predictor of class membership. 
Results
Data characteristics
Table 1 shows sociodemographic and clinical characteristics of the sample. Patients 
participated for a maximum of 173 weeks. With 267 participating patients this resulted in 
46,191 measurement occasions. Not all patients completed every measurement. In total 
16,860 measurement occasions had to be treated as missing, leaving 29,331 measurement 
occasions left for analysis. The mean duration of participation was 132.2 (SD=45.7) weeks. 
Sleep symptoms were reported at almost half of the completed measurements (46.6%), and 
core symptoms of depression in one-third (35.3%). At 44.9% of the measurements occasions, 
neither sleep symptoms nor core symptoms of depression were reported, and at 26.8% of 










Table 1. Sociodemographic and clinical characteristics of the participants at baseline
Total (N = 267)
% n






































PEP + PC 









Antidepressant use 74.2 198
CIDI depressive symptoms at baseline, # 6.0 (2.1)
> 3 previous episodes 36.8 98
Age at first depression onset, years 31.3 (19.9)
Note. N = number of participants; CAU = Care As Usual; PEP = Psycho-Educational Prevention; PC = 
Psychiatric Consultation; CBT = Cognitive Behavioral Therapy. If not otherwise specified, mean and 









The bidirectional relationship between sleep symptoms and core depressive symptoms
Sleep symptoms
The odds to develop current sleep symptoms was 1.42 larger when core symptoms of 
depression were present the previous week compared with the absence of core symptoms 
the previous week (95% CI 1.20 to 1.67, p<.001). The odds for sleep symptoms to disappear 
was 0.86 smaller when core symptoms were present instead of absent the week before 
the manifest occurred (95% CI 0.75 to 0.99, p=.033). The covariate for the duration of core 
symptoms did not add significant information to the model (Wald’s statistic = 1.73, p=.42). 
The covariate for the duration of sleep symptoms did add significant information to the 
model (odds = 0.99, p<.001), indicating that the prolonged presence or absence decreased 
the chance of a transition.
Core depressive symptoms
The odds to develop current core symptoms was 1.26 larger when sleep symptoms were 
present the week before compared with the absence of sleep symptoms in the previous 
week (95% CI 1.05 to 1.50, p=.012). The odds for core symptoms to disappear was 0.87 
smaller when sleep symptoms were present instead of absent the week before the manifest 
occurred (95% CI 0.76 to 0.99, p=.038). The covariate for the duration of sleep symptoms did 
not add significant information to the model (Wald’s statistic=0.17, p=.92). The covariate 
for the duration of core symptoms did add significant information to the model (odds = 
0.99, p<.001), indicating that the prolonged presence or absence decreased the chance of a 
transition.
Sensitivity analysis: the temporal relationship between other depressive symptoms and core 
symptoms 
The odds to develop core symptoms given the presence instead of the absence of each of the 
remaining symptoms last week was significant for all six symptoms (p≤.003), and the odds 
for core depressive symptoms to disappear when each of the other symptoms was absent 
instead of present the previous week was significant for each symptom as well (p<.001). 
The odds to develop each of the six remaining symptoms given the presence of core 
symptoms in the previous week was significant in all cases (p<.001). The odds that each 
of the six symptoms disappeared given the presence of core symptoms last week was 
significant for 3 out of 6 symptoms (p≤.003), namely fatigue or loss of energy, diminished 
ability to think or concentrate, and recurrent thoughts of death, but not for eating problem, 










Table 2.  Bidirectional relationship between remaining six symptoms and core symptoms 
Manifest OR 95% CI p-value 
Given presence core symptomt-1:
Weight symptomt develops
Weight symptomt disappears















Given presence core symptomt-1:
Motor symptomt develops
Motor symptomt disappears















Given presence core symptomt-1:
Energy symptomt develops
Energy symptomt disappears















Given presence core symptomt-1:
Guilt symptomt develops
Guilt symptomt disappears















Given presence core symptomt-1:
Cognitive symptomt develops
Cognitive symptomt disappears























Given presence core symptomt-1:
Suicide symptomt develops
Suicide symptomt disappears















Note. Manifest Markov modeling was used to investigate the temporal relationship between 
symptoms over time; OR = Odds Ratio; CI = Confidence Interval.
Data-driven subgroups of the 3-year course of sleep symptoms and core depressive 
symptoms 
The optimal model estimated by means of PP-LCGA consisted of 3 classes (table 3). BLRT 
and MLR criteria were used to choose the best model. Even in the 6-class model, the BLRT 
did not become insignificant, although errors occurred and likelihood ratio tests could not 
be computed anymore. Because BLRT did not provide useful information, it was decided 
to choose the best model fit based on MLR statistics. The 3-class model was the most 
parsimonious model with good fit. Visual inspection of the growth models (Figure 1) 
shows that in class 1 (N=61) the proportion of sleep symptoms and core symptoms changed 
simultaneously over time but remained as high as 76% and 72%, respectively, after 3 
years. A similar pattern is visible in class 2 (N=127), albeit with a much steeper decrease in 
proportion of both symptoms over time (with proportions around 12% after 3 years). Class 3 
(N=79) differs from class 1 and 2 in that sleep symptoms seem to be more persistent in this 
group (mean proportion of 47% after 3 years) than core symptoms (approximately 10% after 
3 years).   
Figure 1. Observed growth trajectories for each of the PP-LCGA classes
PP-LCGA = Parallel Processes – Latent Class Growth Analysis; the lines represent fractions of the 









Table 3. Parameter comparison of PP-LCGA
Number of 
classes















































Note. AIC = Akaike Information Criterion; BIC = Bayesian Information Criterion; BLRT = Bootstrap 
Likelihood Ratio Test; LMR = Lo-Mendell-Rubin likelihood ratio test; n = number of participants 
within class; PP-LCGA = Parallel Processes – Latent Class Growth Analysis. Bold refers to the most 
parsimonious model with good fit.
The three classes differed significantly regarding age, occupational status and 
educational level (p<.050, table 4) in baseline clinical characteristics (p<.001), and in the 
amount of missingness (p<.001). In class 1, the amount of missing data (51%) was higher 
than class 2 (33%) and class 3 (31%). Patients in class 1 reported significantly more CIDI 
symptoms at baseline compared with patients in class 2 (mean difference = 1.4, SD = 0.3, 
p<.001), and patients in class 3 also reported significantly more CIDI symptoms at baseline 
compared with patients in class 2 (mean difference = 0.9, SD = 0.3, p=.007). Patients in class 
1 were significantly older (mean age = 46.2 years), were more often unemployed, and had a 
lower level of education compared with patients in the other two classes. Patients in class 
2 were the youngest (mean age = 40.8 years) and had the highest education level. Class 3 
consisted of people who obtained a medium level of education and mean age (mean age 
= 43.3 years) compared to the other classes. Patients in class 3 were more often employed 
compared with patients in the other two classes (p=.034, table 4), and used antidepressant 
medication a larger proportion of time in comparison with patients in class 2 (mean 
difference = 0.16, p=.009, main effects table 4). This difference in proportion of 0.16 equals 
21 weeks, at a mean study participation of 132 weeks. In other words, patients in class 3 used 
antidepressant medication on average 21 weeks longer compared to patients in class 2. 
Results of the Manifest Markov modeling showed substantial differences between 
the classes regarding the association of changes in core symptoms with the presence or 
absence of sleep symptoms, and vice versa. A graphical representation of the final Manifest 
Markov model per class is presented in Figure S2, Supplemental Content. A summary of the 
prevalence of sleep and core symptoms throughout the study period, and of the prevalence 







































































































































































































































































































































































































































































































































































































































































































































































In class 1, the odds for core symptoms to disappear was 0.43 smaller when sleep 
symptoms were present instead of absent the week before the manifest occurred (95% CI 
0.22 to 0.81, p=.009). The odds for core symptoms to develop given previous’ weeks sleep 
symptoms was not significant (95% CI 0.50 to 1.76, p=.83). The presence or absence of core 
depressive symptoms did not add significant predictive value to changes in sleep symptoms 
(Wald’s statistic = 1.00, p=.61). Altogether this means that in class 1 the state of sleep 
symptoms was significantly associated with subsequent manifests in core symptoms, but 
not the other way around. More specifically, the likelihood of remission of core symptoms 
was reduced in case of presence of sleep symptoms.
In class 2, the odds to develop current sleep symptoms was 2.78 larger when core 
symptoms of depression were present the previous week compared with the absence of core 
symptoms (95% CI 1.85 to 4.17, p<.001). The odds that sleep symptoms disappeared was not 
significantly different due to the absence or presence of previous week’s core symptoms (95% 
CI 0.56 to 1.01, p=.055). In total, core symptoms were significantly associated with changes 
in sleep symptoms (Wald’s statistic = 28.09, p<.001). The odds to develop current core 
symptoms was 2.39 larger when sleep symptoms were present the previous week compared 
with the absence of sleep symptoms the previous week (95% CI 1.54 to 3.71, p<.001). The 
odds that core symptoms disappeared was not significantly different due to the absence 
or presence of previous sleep symptoms (95% CI 0.74 to 1.31, p=.92). Sleep symptoms did 
contribute significantly to the model (Wald’s statistic = 15.09, p<.001). In summary, in 
class 2, the presence of core symptoms increased the chance of developing subsequent 
sleep symptoms, and the presence of sleep symptoms increased the chance to develop 
subsequent core symptoms. The state of both symptoms was not associated with next-week 
remission of one another. 
Finally, in class 3 the odds for sleep symptoms to either develop or disappear given 
previous’ weeks core symptoms did not add significant value to the model (Wald’s statistic = 
2.87, p=.24). Also, the odds for core symptoms to either develop or disappear given previous’ 
weeks sleep symptoms did not add significant value to the model (Wald’s statistic = 2.81, 
p=.25). To summarize, in class 3, the state of sleep symptoms and core symptoms were not 
significantly associated with manifests in one another. 
Discussion
This study was the first to assess the bidirectional relationship between sleep and core 
depressive symptoms by means of multiple repeated assessments in major depressed 
primary care patients. Sleep symptoms were found to be associated with changes in core 
symptoms, and vice versa. Parallel processes – latent class growth analysis showed that 
three latent classes could be identified which differed substantially in the 3-year course, the 
strength, and the direction of the relationship between sleep and core symptoms. 
The current study showed that for participants diagnosed with major depression at 
baseline a bidirectional relationship existed between sleep symptoms and core depressive 
symptoms. This bidirectionality was also found in longitudinal studies that were 









baseline and follow-up) with regard to major depression5,6,12,26,27. Insomnia is associated 
with the development of depression; non-depressed people with insomnia have a twofold 
risk of developing depression6. Interestingly, the three classes that were identified based 
on the course of symptoms over time differed significantly in direction and strength of this 
bidirectional relationship. In class 1, wherein people were on average older, less educated 
and more often unemployed, the presence of sleep symptoms was significantly associated 
with changes in core symptoms, but not the other way around. In class 2 people were on 
average the youngest and highest educated. In this class the presence of both symptoms 
was only associated with the onset of the other symptom, and not the remission of the 
symptoms. This suggests that the presence of each symptom sustains the emergence of 
the other symptom, but that the disappearance of the symptoms is regulated by another 
factor. Lastly, in class 3, which consisted of the highest proportion of employed people, both 
symptoms showed relatively separate courses and acted rather independently from each 
other. This suggests that in this class the course of both symptoms is influenced by or 
associated with separate processes. Therefore, the results of this study implicate the 
presence of (1) sleep being imbedded within depression, in which a change of sleep is 
associated with a small decrease (class 1) or increase (class 2) of sleep and core depressive 
symptoms; and (2) sleep being part of a construct independent of the depression, as 
represented in class 3. Sleep appears to have an independent status in the latter class with 
the highest rate of employment. This suggests that sleep symptoms in this class might be 
associated with external factors, for example related to work (i.e., high workload, stress), 
instead of being a part of MDD. An alternative explanation can be found in the use of 
antidepressants.  In class 3, patients reported antidepressant use on average 21 extra 
weeks in comparison with patients in class 2. It is common knowledge that not sleeping 
well or feeling very sleepy can be a side effect of antidepressant use28. Possibly, the use of 
antidepressants prolonged the continuation of sleep problems in this class. Obviously 
it cannot be ruled out that unmeasured confounding variables underlie the observed 
associations. 
Several methodological limitations should be mentioned. First, data on insomnia and 
hypersomnia were only available in a combined measure of sleep problems in this study. 
This might be suboptimal because insomnia and hypersomnia may be differentially related 
to core depressive symptoms. However, insomnia and hypersomnia regularly co-occur in 
patients with MDD, with more than 25% of patients who suffered from MDD in the past 
year reporting both insomnia and hypersomnia symptoms29. The overall course of MDD in 
these patients did not differ compared to patients who reported only hypersomnia 
symptoms (5.9%) or insomnia symptoms (59.1%). Nevertheless, future studies should 
preferably use separate measures for in- versus hypersomnia. The same holds for the other 
bidirectional symptoms of MDD: change in activity and change in weight; we could not 
differentiate between patients with increased or decreased psychomotor activity, and 
weight gain or weight loss. This is a major limitation, as recent studies suggest that these 
phenotypes of depression may be driven by different processes. Second, Manifest Markov 
modeling was used to estimate reciprocity between sleep and core symptoms. The type of 
interviewing used in the study (3-monthly, retrospectively over the past 12 weeks) may have 









the statistical model. Findings could be partly explained by shared method variance. Both 
sleep and core symptoms were assessed with the same instrument designed to evaluate the 
symptoms of depression. Other methods of assessing sleep that do not rely on the same 
interview (e.g. sleep diaries30, actigraphy) are less likely to be confounded with depressive 
symptoms. Still, this is the only study in which multiple repeated assessments were used, 
in contrast with earlier studies in which only two assessments were used to examine the 
bidirectional relationship between sleep symptoms and depression6,12. A third limitation 
is the fact that Manifest Markov modeling only uses previous measurements in association 
to current measurements31 while earlier measurements are not taken into account. The 
duration of the presence of a symptom can be important in predicting changes, therefore 
two covariates were created to account for earlier measurements. The additional effects 
of these covariates were, however, found to be non-significant. At last, the sensitivity 
analyses revealed that the importance of sleep symptoms should be considered in a 
realistic perspective, as most of the other symptoms showed significant associations with 
the (dis)appearance of core symptoms as well. This indicates that though the impact of sleep 
symptoms on onset or remission of core depressive symptoms and vice versa is 
substantial, it is probably not unique. Another point of interest is that the amount of 
missingness could have influenced the class membership of the participants. Missingness 
may depend on class membership or the growth trajectory over time (in our case, reaching 
remission). Possibly, the non-remitters had the highest missingness due to severity of their 
depression. Unfortunately, there is not much literature available about the effects of data 
missing not at random in growth models32, and it is mere speculation whether this affected 
class membership in this study. 
The results of the present study hold some important clinical implications, especially 
with regard to the sequencing and selection of depression treatment. The key difference 
between classes was in the degree of remission; class 1 consisted of non-remitters, class 
2 of remitters, and class 3 of partial remitters. Imaginably, patients in class 1 need more 
intensive treatment because their symptoms did not improve during the study period of 3 
years. Treatment of depression resulted in a lasting decline of core symptoms in class 2 and 
class 3, and also resulted in a decline of sleep symptoms in class 2. In class 3, treatment of 
the persistent sleep disturbances following depression treatment may ultimately be helpful 
to establish more complete and sustained remission. In particular because sleeping 
problems may trigger core symptoms while core symptoms in their turn are identified 
as risk factors for of depression relapse33. In class 1, the non-responders, joint treatment 
of sleep and depression treatment may be a key to remission, especially because present 
results showed that changes in sleep were associated with changes in core symptoms in this 
class. Monitoring changes in symptoms over the first months during depression treatment 
could suggest a direction for treatment sequencing and focus that might enhance the 
treatment success. 
In this study the bidirectional relationship between sleep and core symptoms in 
depressed primary care patients with multiple repeated assessments was examined for 
the first time. Different classes of patients were found, namely a class of patients in which 
core symptoms changed independently of sleep symptoms, and two classes in which core 









primary care patients who do not remit should receive more intensive and/or more 
specifically targeted treatment. Second, patients whose core symptoms but not sleep 
symptoms remit should not only be treated for depression but for their sleep disturbances 
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The generic Manifest Markov model was estimated in Latent GOLD® (Statistical 






sla dynamic nominal 2, dep dynamic nominal 2;
equations
sla <- (b1~tra) 1 | sla[-1] + (b2~tra) dep[-1] | sla[-1] + (b3~tra) 
teller_sla_lag | sla[-1] + (b4~tra) teller_krn_lag | dep[-1] sla[-1];
dep <- (c1~tra) 1 | dep[-1] + (c2~tra) sla[-1] | dep[-1] + (c3~tra) 
teller_krn_lag | dep[-1] + (c4~tra) teller_sla_lag | sla[-1] dep[-1];
sla_d_w1_173 <- (a~err) 1 | sla;
krn_d_w1_173 <- (a~err) 1 | dep;
a = -100;
In the variables section we define the caseid variable “id1” connecting the multiple 
records of a person, the latent, dependent, and independent variables to be used 
in the analysis, as well as various attributes of these variables, such as their scale types. 
The term “dynamic nominal 2” indicates that the nominal variables for sleep and core 
symptom may change their values over time, in two possible states. The equations section 
contains five equations. The first two equations represent each response variable. “sla” 
refers to sleep symptom and “dep” refers to core symptom. The logit models for both 
“sla” and “dep” contain an intercept (the term “(b1~tra) 1”), an effect of previous core 
symptom state (the term “(b2~tra) dep[-1]”), an effect of the amount of weeks the 
dependent symptom has been in the same state (the term “(b3~tra) teller_sla_lag”), 
and an effect of the amount of weeks the independent symptom has been in the same 
state (the term “teller_krn_lag”), all conditional on the state of sleep at the previous 
measurement (the term “| sla[-1]”). The third and fourth equation contain the term 
“(a~err) 1” which in combination with “a = -100;” in equation five fixes the logit 
parameters in the model for the response variables to -100. This yields a perfect relationship 
between “sla” and “sla_d_w1_173”, and between “dep” and “krn_d_w1_173”, assuming 









Table S1. Prevalence of sleep and core symptoms throughout study period
Core symptom present Core symptom absent
Total (N=267)
Sleep symptom present 7862 5804
Sleep symptom absent 2510 13155
Class 1 ‘the non-remitters’ (N=61)
Sleep symptom present 3846 557
Sleep symptom absent 488 256
Class 2 ‘the remitters’ (N=127)
Sleep symptom present 1643 1301
Sleep symptom absent 1321 10520
Class 3 ‘the partial remitters’ (N=79)
Sleep symptom present 2373 3946
Sleep symptom absent 701 2379
 
Note. N = number of participants. 
Table S2. Prevalence of the possible transitions
Total Class 1 Class 2 Class 3
Sleep symptom develops 305 43 123 139
Sleep symptom disappears 398 50 187 161
Core symptom develops 257 41 114 102









Figure S1. Graphical representation Manifest Markov Model
Note. Manifest Markov models were used to examine if the state of one symptom (i.e., sleep 
symptoms, with state 0 = absent, and state 1 = present) at time t-1 was associated with a transition in 
the other symptom (i.e. core symptoms, with transition possibilities from ‘0 = absent’ to ‘1 = present’, 
and from ‘1 = present’ to ‘0 = absent’) at time t and vice versa. Dotted lines represent transition, solid 
lines represent association with the transition.
 
Figure S2. Graphical representation Manifest Markov Models per class
Note. Bold lines represent significant associations with transitions. This means that in class 1, a 
transition in core symptoms this week (time t) was associated with the state of sleep symptoms the 
previous week (t-1). In class 2, next to that, a transition in sleep symptoms this week was associated 
with the state of core symptoms the previous week. In class 3, no significant association with a 
















This thesis was aimed at examining the role of sleep in the context of MDD from a 
physiological and a behavioral perspective. For this purpose intensive longitudinal designs 
with short time scales were used and relatively novel statistical techniques were applied. 
This approach enabled to examine short-term temporal dynamics between sleep and other 
MDD-related variables, and enabled to find out what possibilities there are to target sleep 
parameters in the prevention and treatment of MDD. In this chapter I will discuss the 
main findings, methodological considerations, clinical implications, and future research 
directions.
Dynamics
Earlier studies showed that sleep plays an important role in the development and 
recurrence of MDD1-4. The role of sleep at a shorter time scale has not been explored much5, 
just as the temporal ordering among sleep and other variables like affect and physical 
activity, variables that are important in the context of MDD. I started with a physiological 
point of view and a within-day approach to explore within-day dynamics of the melatonin 
in Chapter 2 and Chapter 3. Then I moved on to a behavioral approach, and a day-to-day time 
frame, to explore the temporal dynamics between sleep quality and positive or  negative 
affect in Chapter 4, and to explore the temporal order of change between sleep quality or 
quantity and physical activity in Chapter 5. In Chapter 6 I used a design with a week-to-week 
time frame to investigate the bidirectional dynamic relationship between sleep symptoms 
and core depressive symptoms of MDD. In this chapter was also investigated how sleep and 
core depressive symptoms developed over a 3-year course, and whether subgroups could be 
identified based on differences in this course. Furthermore was investigated whether the 
identified subgroups could be characterized by differences in the bidirectional relationship 
between sleep and core depressive symptoms. 
A physiological perspective on the role of sleep
Earlier studies pointed towards the potential importance of melatonin in the context of 
MDD6,7. Disrupted endogenous melatonin secretion levels were thought to be associated 
with episodes of MDD6,7, and exogenous melatonin administration had been found to 
improve MDD status8. However, most studies applied a cross-sectional design or measured 
melatonin secretion for a maximum of 24 hours9 and did not take possible intra- and 
interindividual variation in endogenous melatonin secretion levels into account. I 
therefore started by exploring the stability, within-day and between-day dynamics of 
endogenous melatonin secretion in depressed and non-depressed participants in Chapter 
2. Both depressed and non-depressed participants showed day-to-day variability in their 
endogenous melatonin secretion. On average depressed participants showed significantly 
more variance and higher melatonin levels than the non-depressed participants (p<.05). 
In Chapter 2 was shown that in some participants, higher melatonin levels were 
association with time of antidepressant intake (evening intake). Next to these 
communalities at the level of the group, a high degree of interindividual variation in 







enabled to investigate whether these dynamics were related to dynamics in fatigue and 
positive and negative affect. In Chapter 3 again depressed and non-depressed participants 
were investigated. In the majority of participants within-day changes in endogenous 
melatonin secretion were temporally or contemporaneously associated with within- 
day changes in positive or negative affect or fatigue, but with substantial interindividual 
differences in the strength and direction of the association. One explanation of these 
differences is heterogeneity between participants. An alternative explanation for these 
differences is that the findings at the level of the individual might represent a type I error 
(false positive). There were twelve possible associations between melatonin and affect or 
fatigue per participant. At an ηα-level of .05, this means that in at least 50% of the 
participants, the significant melatonin association could reflect a chance finding. Still, 
83% of the participants did show associations of melatonin secretion with fatigue, positive 
affect, or negative affect, which suggests that the finding represents more than just a type 
I error. Participants in this group, with associations between melatonin and fatigue or 
affect, reported higher sleep quality than participants in who no associations were 
estimated between melatonin and fatigue or affect.  
Overall, the findings of Chapter 2 and Chapter 3 do not point towards a specific role of 
melatonin dynamics in the context of depression. The results did not show characteristic 
associations of melatonin dynamics for depressed versus non-depressed participants. 
Remarkably, in a small subgroup of participants with most severe depression scores (N=4), 
melatonin dynamics were not associated with fatigue or positive or negative affect. A 
possible - but tentative - explanation for this finding is that there is often a lack of daily 
structure in patients who suffer from severe depression, which might be associated with 
the circadian rhythm being “out of tune”. As a result, the natural ebb and flow of melatonin 
secretion levels (low in the morning, high in the evening), of affect (high in the morning, 
low in the evening), and of fatigue (low in the morning, high in the evening) could be 
dysregulated and therefore lose associations with each other. It would be interesting to 
further investigate if this idea is correct, to find out whether and how melatonin dynamics 
are associated with fatigue and affect in other severely depressed patients, and if so, to 
investigate whether applying a strict daily structure might be beneficial for these patients.
 
A behavioral perspective on the role of sleep 
In Chapter 4, Chapter 5, and Chapter 6 I changed to a behavioral perspective on the role 
of sleep in depression. I found that changes in sleep were unidirectional associated with 
day-to-day changes in affect and physical activity. In Chapter 4 was shown that changes 
in sleep quality were associated with changes in subsequent positive and negative affect, 
but not vice versa. The temporal association from sleep quality to positive and negative 
affect was partly mediated by fatigue. Then, in Chapter 5 was investigated whether day- 
to-day changes in physical activity and sleep quality or quantity were associated with each 
other. Again, changes in sleep were associated with subsequent changes in physical activity, 
but not vice versa. To be more specific: an increase in sleep duration was associated with 
a decrease in next-day physical activity. Chapter 6 was aimed at investigating the dynamic 
association between sleep and mood during episodes of depression and remission. The 







recurrence of MDD, but also affects week-to-week changes in core symptoms of MDD 
during depressive episodes, remission, and recurrence. This was also found the other way 
around: week-to-week changes in core symptoms were associated with the course of sleep 
symptoms of MDD during depressive episodes, remission, and recurrence. To be more 
specific: the current state of core symptoms was associated in next-week changes in sleep 
symptoms (either development or remission), and vice versa, the current state of sleep 
symptoms was associated with next-week changes in core symptoms. Contrary with the 
findings from Chapter 4, in which a unidirectional association was found from day-to-day 
changes in sleep quality to subsequent affect, in Chapter 6 a bidirectional association was 
found between week-to-week changes in sleep symptoms and core depressive symptoms. 
A second aim of Chapter 6 was to derive meaningful subgroups that differed in their 3-year 
course of sleep symptoms and core depressive symptoms. I identified 3 classes that were 
substantially different during the 3-year course of sleep symptoms and core depressive 
symptoms. The 1st class was characterized by persistence of both symptoms during those 
3 years, and a unidirectional association from week-to-week changes in sleep symptoms 
to subsequent core depressive symptoms. In the 2nd class both symptoms remitted and a 
bidirectional association between sleep symptoms and core depressive symptoms was 
found. In the 3rd class the sleep symptoms remitted less steeply than the core symptoms 
during those 3 years, while no association whatsoever was found between week-to-week 
changes in sleep and core depressive symptoms. 
In conclusion, the abovementioned chapters suggest that sleep dynamics play a 
role in behavioral aspects of depression. Most interesting is the contradiction in results 
between day-to-day and week-to-week intervals. Investigating day-to-day dynamics 
resulted in a unidirectional association in which sleep dynamics always preceded dynamics 
in affect or physical activity. Contrary, when week-to-week dynamics were investigated, a 
bidirectional association was found between sleep and core depressive symptoms. Possibly, 
sleep responses slower to change than affect and physical activity, and therefore 
associations between affect or physical activity and subsequent sleep can only be detected 
in studies with a time interval of a few days. Another explanation could be that sleep is less 
responsive to change than affect and physical activity. Lower responsiveness would explain 
why changes in sleep were only detectable in the design where sleep and core depressive 
symptoms were assessed weekly instead of daily. 
Heterogeneity 
The application of intensive longitudinal designs enabled to overcome the problem of 
heterogeneity that was mentioned in Chapter 1. Interindividual differences were taken 
into account in every chapter of this thesis, and in each chapter substantial intra- and 
interindividual differences were revealed. Both depressed and non-depressed participants 
showed intra- and interindividual differences in the examined associations. Taking these 
differences into account added relevant information that would otherwise have remained 
undetected, especially in Chapter 2 and Chapter 3, namely that melatonin secretion levels 







resemble associations at the level of the individual participant (Chapter 3). Significant 
information would have been overlooked or lost would we not have examined individual 
patterns in both chapters. Both results show that the investigation of heterogeneity can 
add relevant information about fluctuations within participants and differences therein 
between participants who are part of the same group. In Chapter 4 and in Chapter 5 we 
also found substantial interindividual heterogeneity in the strength and direction of the 
examined associations. Significant associations were found at the level of the group despite 
this heterogeneity among participants. The same holds for the results of Chapter 5: 
significant group-level associations were estimated despite substantial interindividual 
heterogeneity in the strength and direction of the temporal association between sleep 
duration and subsequent physical activity. Differences in strength and direction of the 
temporal associations could not be attributed to diagnostic status in any of the 
abovementioned chapters. In the study of Chapter 6, in which only MDD patients were 
included, interindividual heterogeneity was taken into account as well. Despite the 
heterogeneous character of MDD, significant associations that predicted the likelihood of 
changes occurring at the level of the group and at the level of three subgroups could still be 
estimated.
In conclusion, this thesis shows that heterogeneity should be taken into account 
because this results in additional knowledge that would otherwise remain unnoticed. 
Besides, the amount of heterogeneity shows the need for tailor-made interventions, 
because the interindividual differences emphasizes that average associations at the level of 
the group are not always representative for the strength and direction of the association at 
the level of the individual. 
   
   
Ecological validity
The third factor that I considered as a difficulty of more traditional approaches was the 
restricted ecological validity. The ecological validity of the MOOVD data was relatively 
high: ambulatory assessments were used to monitor affect and behavior thrice a day with 
6h-intervals. The participants collected the data in their natural environment, fluctuations 
over time were modeled, and interindividual heterogeneity was taken into account10,11. 
This increased the translatability of our study results to daily life of depressed and non- 
depressed people. The data that were used in Chapter 6 were less precise because of longer 
time intervals between measurements and the retrospective design. Weekly symptom 
presence was assessed once every 3 months, not every week. Still, the ecological validity of 
this study was higher than more traditional studies because participants’ symptom course 
was monitored in their natural environment, and because the longitudinal design enabled 









The use of intensive longitudinal data enabled to investigate the role of sleep from a 
different point of view. It was possible to model temporal dynamics, heterogeneity was 
taken into account which revealed otherwise unnoticed information, and results had higher 
levels of ecological validity. However, there are some factors that should be kept in mind 
with regard to intensive longitudinal designs. 
A major difficulty of intensive longitudinal designs is choosing the time interval and 
the duration length of the study. As already mentioned in Chapter 1, the time interval 
depends on the type of research questions at hand. The difficulty is that most often there 
will be more than one question to be answered: the datasets that emerge from intensive 
longitudinal designs contain a lot of information on several parameters. For example, the 
MOOVD study contained over 60 parameters. The time between intervals and duration of 
the study should be chosen in such way that fluctuations in multiple types of parameters 
can be captured. In our case, it was unfortunate that we had “only” 30 measurements of 
sleep in the MOOVD dataset, because sleep fluctuates between and not within days. This 
disabled the inclusion of the sleep measurement in the GIMME analyses of Chapter 3. 
On the other hand, the MOOVD dataset was quite unique: because melatonin fluctuates 
within days, we had up to 90 measurements of melatonin, and we therefore could unravel 
questions about stability and day-to-day stability and change that had remained unanswe-
red up to now. 
Another point that should be kept in mind is that even though intensive longitudinal 
designs open up interesting ways to look at a certain topic, it is a time-consuming and 
expensive way to perform research. I would therefore advise to only use this approach in 
case more traditional designs give unsatisfactory answers and a closer look at a dynamic 
process or information about individual differences is needed.
Modeling temporal dynamics
A major methodological advantage of intensive longitudinal data is the possibility to model 
temporal dynamics of change and thus the order of effects between parameters. This is not 
possible with cross-sectional or panel designs with only a few assessment waves. In fact, 
knowledge about the order of change is a major step forward towards knowledge about 
causality. However, a fundamental mistake that is often made is that when temporal 
associations are estimated, this would equal causality between parameters. Articles often 
discuss how parameter x “influences” parameter y, and how changes in parameter y 
“caused change” in parameter z. For sake of comfort we tend to use terms that imply 
causality but this is not the case. Nonetheless, when approaches like the ones in this 
thesis are used, results always consider associations instead of causation. In that regard the 
term “Granger causality”12 is unfortunate and can be misleading, because strong evidence 
of Granger causality may be weak evidence of a causal relationship between variables. Of 
course the type of the design can make a researcher suspect a causal relationship between 







intervention study in which the suspected cause will be triggered to find out whether this 
influences the suspected reaction. I will further elaborate on this in the paragraph Future 
Directions. 
In this thesis I used several statistical approaches to investigate temporal dynamics 
from a time series perspective (Chapter 2-5) or from an epidemiological perspective 
(Chapter 6). In Chapter 2 we used autoregressive integrated moving average13 (ARIMA) 
modeling because we wanted to model individual time series. This is a useful approach 
in case the dynamics of individual time series have to be mapped. In case individual time 
series’ interdynamics should be analyzed at the level of the group ánd the individual, group 
iterative multiple model estimation14 (GIMME; Chapter 3) is a more suitable approach. The 
benefit of this approach is that multiple individual time series can be analyzed 
simultaneously at the level of the group and at the level of the individual. Obviously 
this method also has some disadvantages. The first difficulty of GIMME is that the 
contemporaneous associations are pointed in a direction, which suggests a certain 
ordering in the association. Statistically the ordering can be explained by the fact that when 
multiple parameters are modeled, parameter x can explain a larger part of the variance 
in parameter y, than parameter y explains of the variation in parameter x, because other 
parameters also explain a certain amount of the variance in x and y. Explaining this 
theoretically becomes much more of a challenge, because the question how temporal 
ordering can be detected in parameters that were measured at exactly the same moment 
in time, is very difficult to answer. GIMME developers suggest that directed 
contemporaneous associations reflect relations occurring at increments less than the 
measurement interval. In my opinion modeling unmeasured fluctuations that occur within 
an interval is statistically impossible. I would therefore advise to explain this directed 
association only as a matter of differences in the percentage of explained variance.
In Chapter 4 and Chapter 5 a multilevel approach was applied. This approach is of 
great use when the researcher is interested in average group associations and wants to 
take individual heterogeneity in these associations into account. In multilevel modeling, a 
normal distribution of parameters is assumed. When data is largely heterogeneous and in 
case multiple subgroups with substantially different parameter distributions are present, 
modeling average results will be of little added value because the average group result will 
not mirror associations at the level of the individual. A major advantage of GIMME in 
comparison to multilevel modeling is that not average levels but the number of participants 
that show a certain association are considered. The number of participants that should 
show the same association can be randomly chosen by the researcher, which is another 
disadvantage of GIMME analyses. The criterion of >75% to represent the majority of the 
sample should be followed as a cutoff score14. An advantage of manipulating the criterion 
is that the researcher can raise the percentage to test the robustness of the findings, for 
example whether the findings hold in >95% of participants. In the multilevel modeling, best 
linear unbiased prediction15 (BLUP) was used to estimate the strength and direction of the 
individual associations. The estimated BLUP coefficients do not provide information about 
the exact association at the level of the individual. Therefore, this approach is less suitable 







Lastly, in Chapter 6 Manifest Markov modeling16 was used. This approach is especially 
suitable when a researcher is interested in moments of change. Drawback of this method 
is the assumption that only the measurement at t-1 influences these moments of change. 
Besides, although Manifest Markov modeling enables to investigate patterns at the level of 
the group while taking individual heterogeneity into account, the model does not provide 
information about interindividual heterogeneity or random effects. 
It may be clear that the choice of method largely depends on the research. In 
conclusion, I would advise the following: if the individual-level associations are most 
important, use methods that analyze the data at the level of the individual such as ARIMA 
or VAR. If the main interest lies in average group-levels and the degree of heterogeneity I 
would advise a multilevel approach or Manifest Markov modeling, and if the main interest 




This thesis stresses that dynamics of sleep are associated with MDD core symptoms 
and MDD-related factors fatigue, affect, and physical activity. The findings hold some 
suggestions for clinical practice, which I will further discuss below. 
The first implication is related to melatonin secretion. One of the findings of Chapter 
2 was that the time of antidepressant intake might mediate the effect of the antidepressant 
on melatonin secretion, because increased melatonin secretion was associated with 
evening intake of citalopram and amitriptyline. Heightened melatonin secretion levels may 
induce daytime feelings of fatigue8. Increased fatigue is a disadvantageous side-effect, 
especially in the context of MDD, because depressed patients already report higher feelings 
of tiredness throughout the day. Therefore the clinician should pay attention to this 
potential side-effect of antidepressants on melatonin secretion and eventually change the 
time of intake to find out whether this benefits the patient. 
The second implication is related to associations of sleep with affect, physical 
activity, and core depressive symptoms. Chapter 4, 5, and 6 showed that changes in sleep 
were associated with subsequent behavioral changes, and in case of Chapter 6, changes 
in core depressive symptoms were also associated with subsequent changes in sleep. 
Altogether these temporal associations suggest that sleep plays a role in behavioral aspects 
that are related to depression in both depressed and non-depressed people. A sleep- 
oriented approach might therefore be beneficial in prevention and treatment of behavioral 
aspects such as negative affect, low physical activity, and sad mood. Unfortunately, 
clear-cut advice about the effects of sleep on behavior and depression course cannot be 
given because causality was not investigated in this thesis (more on this in the paragraph 
Future Directions). On the other hand, I’m not aware of cases in which improvement of sleep 
ever harmed people. Knowing that the absence of sleep disturbances is associated with a 
lower risk of future health complaints compared to the presence of sleep disturbances17,18, 
makes me question why sleep did not yet receive more attention in clinical practice. 







practice. Examples of sleep hygiene advice are: always go to bed at the same time, sleep in 
a dark, cool, silent room, avoid alcohol, caffeine, and heavy meals before sleeping, practice 
exercise during the day, don’t nap after 4pm, and do relaxation before sleeping. This may be 
a first step towards carefully implementing a sleep-oriented approach in clinical practice. 
Stronger recommendations can be made after thoroughly investigating causality between 
sleep and behavior.
The finding that substantial interindividual differences were found in the strength 
and even direction of associations in each chapter of this thesis emphasizes the need for 
a tailor-made patient approach. Most treatment advice is based on average group results 
and therefore the advice does not mirror the patient in front of the clinician. The 
abovementioned advices should be taken into consideration in the light of this 
heterogeneity, and should be adapted to individual needs of the patient. Finding out what 
works for each individual patient by means of an intensive longitudinal approach (i.e., diary 
study) would be too time-consuming and intense in terms of patient burden and workload 
for the clinician. I therefore recommend keeping in mind that sometimes the average 
treatment approach will not work for the patient, and in that case, the patient might benefit 
from keeping a daily diary so that dysfunctional patterns over time can be mapped. 
Future directions
The most important recommendation for future research concerns the investigation 
of causality. It would be of great informative value to find out whether experimentally 
manipulated changes in sleep quality or quantity can actually predict beneficial changes 
in behavior associated with MDD, in MDD core symptoms, or in MDD course. Knowing 
this would finally provide clear-cut starting points for prevention and treatment. If the 
treatment of sleep disturbances point out to be beneficial, targeted treatments can be 
implemented in clinical practice, which may eventually lead to a decrease of MDD 
prevalence. Not only knowing that sleep is associated with MDD, but also knowing how 
we can start taking advantage of this might benefit the prevention and treatment of MDD. 
Another important factor to keep in mind in future research is that although sleep is 
now a popular topic and seems important in the prevention and treatment of MDD, there 
are several other factors that should be investigated as well. The contribution of sleep is 
not unique. As long as dynamics, heterogeneity, and ecological validity are considered, 
future research will bring us closer to a tailored approach of MDD in which we know what 
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De dynamische rol van slaap in de context van depressie
Depressie is een van de meest voorkomende geestelijke gezondheidsproblemen in het 
Westen. Een depressieve stoornis kenmerkt zich door een chronisch-terugkerend beloop. 
De beschikbare behandelingen voor depressie slaan niet bij elke patiënt goed aan. 
Ongeveer 35% van de depressieve patiënten knapt niet op na behandeling en in zo’n 15% van 
de patiënten treedt slechts gedeeltelijk herstel op. Een gevolg van gedeeltelijk herstel is dat 
symptomen aanwezig blijven, wat het risico op een nieuwe depressieve episode verhoogt. 
Slaapproblemen behoren tot de symptomen van depressie (zie Box 1); 70% van de 
depressieve patiënten rapporteert slaapproblemen. Slaapproblemen vormen een 
risicofactor voor het ontwikkelen van een depressieve stoornis en blijven bij ongeveer 40% 
van de patiënten over als residueel symptoom na behandeling van de depressieve stoornis, 
wat het risico op terugkeer van de depressie verhoogt. 
Box 1. Symptomen van depressie volgens DSM-V
(1) Sombere stemming, gedurende het grootste deel van de dag en bijna elke dag, zoals blijkt uit 
ofwel subjectieve mededelingen, ofwel observatie door anderen.
(2) Duidelijk verminderd(e) interesse of plezier in alle of bijna alle activiteiten, gedurende het  
grootste deel van de dag, bijna elke dag.
(3) Significant gewichtsverlies zonder dat dieet wordt gehouden, of gewichtstoename, of bijna elke 
dag een afgenomen of toegenomen eetlust.
(4) Insomnia of hypersomnia bijna elke dag
(5) Psychomotorische agitatie of vertraging, bijna elke dag.
(6) Vermoeidheid of verlies van energie, bijna elke dag.
(7) Gevoelens van waardeloosheid of buitensporige of onterechte schuldgevoelens bijna elke dag.
(8) Verminderd vermogen tot nadenken of concentreren, of besluiteloosheid, bijna elke dag.
(9) Recidiverende gedachten aan de dood, recidiverende suïcidegedachten zonder een specifiek of 
een suïcidepoging, of een specifiek plan om suïcide te plegen.
Ondanks dat bekend is dat slaapproblemen een risico vormen voor het ontstaan 
van een depressie en terugkeer van een depressieve episode, en dat slaapproblemen en 
depressie elkaar versterken, is weinig bekend over de kortere-termijn effecten van slaap 
in de context van depressie. Waarschijnlijk heeft het gebrek aan kennis over de rol van 
slaap bij depressie op korte termijn ertoe geleid dat slaapproblemen tot op heden weinig 
aandacht gekregen hebben in de behandeling van depressie. Interventies met betrekking 
tot de verbetering van slaap worden niet of nauwelijks genoemd in behandelrichtlijnen en 
protocollen voor depressie. Eerdere ‘traditionele’ studies richtten zich voornamelijk op de 
lange-termijn effecten van slaapproblemen op depressie. Met traditionele studies worden 
cross-sectionele studies, cohort studies met enkele meetmomenten en studies die in een 
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laboratorium uitgevoerd zijn bedoeld. Drie methodologische factoren die inherent zijn aan 
deze traditionele designs bemoeilijken het onderzoeken van depressie: (1) veranderingen 
en de volgorde waarin deze veranderingen optreden kunnen niet in kaart worden gebracht; 
(2) heterogeniteit tussen personen wordt vaak niet meegenomen; en (3) de ecologische 
validiteit is beperkt, wat betekent dat resultaten niet goed aansluiten bij wat gebeurt in de 
klinische praktijk en het dagelijks leven van onderzochte personen.
Het hoofddoel van dit proefschrift was het identificeren van de dynamische rol van 
slaap in de context van depressie. Intensieve longitudinale onderzoeksdesigns en relatief 
nieuwe statistische technieken werden benut zodat dynamiek (veranderingen) in kaart 
kon worden gebracht, heterogeniteit tussen personen kon worden meegenomen en de 
ecologische validiteit groter was dan bij traditionele onderzoeksdesigns en daarmee de 
onderzoeksbevindingen beter vertaalbaar naar het dagelijks leven en de klinische praktijk. 
Intensieve longitudinale studies hanteren een onderzoeksdesign waarbij bij elk individu 
vele herhaalde metingen worden verricht. Een dergelijk design resulteert in een tijdreeks 
van informatie per individu. Afhankelijk van het tijdsinterval tussen metingen van deze 
tijdreeks, kunnen verschillende vragen beantwoord worden over de volgorde waarin 
veranderingen over de tijd plaatsvinden. In dit proefschrift werden twee perspectieven 
op dergelijke veranderingen onderzocht: een fysiologisch perspectief, waarin melatonine 
centraal stond, en een gedragsperspectief, waarin slaapkwaliteit en slaapkwantiteit, 
positief en negatief affect, fysieke activiteit, en depressiebeloop centraal stonden. Naast 
de analyse van tijdreeksen op groepsniveau, om overeenkomsten en verschillen in 
fysiologie en gedrag te detecteren, konden per individu persoon-specifieke processen in 
kaart gebracht worden. Bij het verzamelen van tijdreeksen wordt vaak gebruik gemaakt van 
ambulante metingen. Ambulante metingen vormen een verzamelterm voor meetmethoden 
waarbij personen gegevens verzamelen in hun natuurlijke omgeving, bijvoorbeeld door 
thuis speekselmonsters te verzamelen om melatoninesecretie te monitoren, een dagboek 
bij te houden van stemming door de dag heen, of een armband te dragen waarin fysieke 
activiteit constant wordt geregistreerd. In dit proefschrift wordt op een dergelijke 
vernieuwende manier de rol van slaap in depressie onderzocht, wat uiteindelijk 
aangrijpingspunten kan opleveren voor het verbeteren van de preventie en behandeling 
van depressie. 
Een fysiologisch perspectief 
In het eerste deel van dit proefschrift werd de rol van slaap vanuit een fysiologisch 
perspectief onderzocht. Aanleiding hiervoor waren eerdere studies die het potentieel 
belang van melatonine in de context van depressie lieten zien. Verstoorde melatonine- 
secretie zou gerelateerd zijn aan depressieve episodes en depressieve patiënten zouden 
kunnen profiteren van het innemen van melatonine-supplementen. In deze eerdere 
studies werd een cross-sectioneel design gebruikt of werd het melatonineniveau 
maximaal 24 uur lang gemeten. Hierdoor werd niet duidelijk hoe stabiel of variabel 
melatoninesecretie van dag tot dag is en of deze variabiliteit en stabiliteit verschilt tussen 
individuen. In Hoofdstuk 2 werd daarom exploratief de stabiliteit en variabiliteit van 
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melatoninesecretie onderzocht met herhaalde metingen. Daarnaast waren wij 
geïnteresseerd in de vraag of de stabiliteit en variabiliteit van melatoninesecretie 
verschillend zou zijn voor depressieve en niet-depressieve personen. Depressieve (n=10) 
en niet-depressieve (n=10) deelnemers verzamelden op 30 achtereenvolgende dagen, 
3 keer per dag, speekselmonsters waarvan met behulp van massaspectrometrie het 
melatonineniveau gemeten werd. We vonden dat de stabiliteit van melatoninesecretie 
gemiddeld genomen lager was in de groep depressieve personen dan in de groep niet- 
depressieve personen, en dat depressieve personen over het algemeen meer melatonine 
uitscheidden dan niet-depressieve personen. Naast deze groepsbevindingen werd zowel bij 
depressieve als niet-depressieve deelnemers veel variatie tussen personen (heterogeniteit) 
gevonden in de hoeveelheid uitgescheiden melatonine gedurende 30 dagen. Bij sommige 
personen waren hogere melatonineniveaus gerelateerd aan de inname van antidepressiva 
in de avond. Samengevat liet Hoofdstuk 2 zien dat er door de grote mate aan gevonden 
variatie geen karakteristieke rol voor melatoninesecretie in de context van depressie is. 
Wel kon gezegd worden dat melatoninesecretie varieert van dag tot dag. Door de gevonden 
variatie in melatoninesecretie ontstond een nieuwe onderzoeksvraag: zouden 
veranderingen in melatoninesecretie samenhangen met veranderingen in affect en 
vermoeidheid? Dit zou een duidelijker aanknopingspunt geven voor een mogelijk verband 
tussen melatoninesecretie en depressie.
In Hoofdstuk 3 werd met behulp van een relatief nieuwe statistische methode (GIMME) 
onderzocht of veranderingen in melatoninesecretie geassocieerd waren met 
veranderingen in affect en vermoeidheid. We onderzochten hiervoor opnieuw 
depressieve (n=14) en niet-depressieve personen (n=15). We vonden dat in de meerderheid 
van de depressieve en niet-depressieve personen veranderingen in melatoninesecretie 
binnen de dag gerelateerd waren aan gelijktijdige of daaropvolgende veranderingen in 
positief affect, negatief affect of vermoeidheid. Als voorbeeld: een verhoging in melatonine 
in de ochtend hing bij enkele personen samen met een verbetering van positief affect in 
de middag. Personen waarbij een verband gevonden werd tussen melatonine en affect of 
vermoeidheid rapporteerden een betere slaapkwaliteit dan personen waarbij geen verband 
gevonden werd tussen melatonine en de overige variabelen. Ondanks dat in 83% van de 
personen een verband gevonden werd tussen melatonine en de andere variabelen, werden 
deze verbanden gekenmerkt door substantiële verschillen. Die verschillen betroffen zowel 
de sterkte als de richting van het verband en konden niet verklaard worden door 
depressiestatus. De overgrote meerderheid van de personen waarin géén verband tussen 
melatonine en de overige variabelen gevonden werd (17% van de deelnemers), had erg 
hoge depressiescores. Een mogelijke maar speculatieve verklaring zou kunnen zijn dat het 
gebrek aan dagelijkse structuur bij depressie gerelateerd is aan een circadiaan ritme dat 
‘uit de pas loopt’. Hierdoor zouden de natuurlijke pieken en dalen van melatoninesecretie 
(laag in de ochtend, hoger in de avond), affect (goed in de ochtend, slechter in de avond) 
en vermoeidheid (laag in de ochtend, hoger in de avond) gedereguleerd kunnen zijn en het 
verband met elkaar verloren hebben. Het zou interessant zijn verder te onderzoeken of dit 
vaker voorkomt bij patiënten met ernstige depressie, en als dit het geval is, of het 
aanbrengen van een vaste structuur in het dagelijks leven een positief effect zou hebben 
op deze patiënten. Ondanks deze opvallende bevinding kon door de heterogeniteit in 
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resultaten en de kleine groepsgrootte ook in dit hoofdstuk geen duidelijke rol vastgesteld 
worden van melatonine in de context van depressie. 
Een gedragsperspectief 
In het tweede deel van dit proefschrift werden slaap en depressie vanuit een 
gedragsperspectief onderzocht. Allereerst werd gepoogd een antwoord te vinden op de 
volgende vragen: Wat is de volgorde van veranderingen in slaapkwaliteit en positief of 
negatief affect? Verschilt deze volgorde tussen depressieve en niet-depressieve personen? 
Als een verandering in slaapkwaliteit voorafgaat aan een verandering in affect, wordt dit 
verband dan gemedieerd door vermoeidheid (bijvoorbeeld: slechte slaapkwaliteit in de 
afgelopen nacht leidt tot meer vermoeidheid in de ochtend, wat leidt tot minder positief 
affect gedurende de dag)? Andersom, is verandering in affect gedurende de dag 
voorspellend voor een verandering in slaapkwaliteit de daaropvolgende nacht, en zo ja, 
wordt dit verband gemedieerd door piekeren gedurende de avond? In Hoofdstuk 4 werd 
getracht deze vragen te beantwoorden, waarbij gebruik gemaakt werd van 
tijdreeksgegevens van depressieve (n=27) en niet-depressieve personen (n=27). 
Verbeteringen in slaapkwaliteit gingen vooraf aan verbeteringen in positief en negatief 
affect. Een toename in slaapkwaliteit voorspelde meer positief en minder negatief affect 
gedurende de dag. Andersom vonden we geen verband: veranderingen in positief of 
negatief affect gingen niet vooraf aan veranderingen in slaapkwaliteit. De gevonden 
verbanden waren niet verschillend voor depressieve en niet-depressieve personen. Het 
gevonden verband tussen slaapkwaliteit en positief en negatief affect werd deels 
gemedieerd door vermoeidheid: een toename in slaapkwaliteit voorspelde een afname 
in vermoeidheid gedurende de dag, wat weer een verbetering in positief affect en een 
vermindering in negatief affect tot gevolg had. 
In Hoofdstuk 5 werd de focus verlegd van affect naar fysieke activiteit. We 
onderzochten opnieuw de volgorde van veranderingen, ditmaal in de mate van fysieke 
activiteit gedurende de dag en slaapkwaliteit of -kwantiteit gedurende de nacht, en gingen 
na of de gevonden verbanden verschillend waren voor depressieve (n=27) en niet- 
depressieve personen (n=27). We vonden op groepsniveau weer een verband waarbij 
veranderingen in slaapkwantiteit gerelateerd waren aan daaropvolgende veranderingen in 
fysieke activiteit, en niet andersom. Een toename in slaapduur de afgelopen nacht had een 
afname in fysieke activiteit de daaropvolgende dag tot gevolg. Naast deze groepsbevinding 
vonden we substantiële verschillen tussen personen in de sterkte en richting van de 
verbanden. Dit hoofdstuk leverde de vraag op hoe het kan dat een verbetering van slaap 
leidt tot een afname in fysieke activiteit. Een mogelijke verklaring is dat een langere 
slaapduur zorgt voor activatie van het parasympathische zenuwstelsel. Het 
parasympathische zenuwstelsel regelt lichaamsfuncties op momenten van rust en slaap. 
Activatie hiervan zorgt dat de hartslag daalt en het maagdarmstelsel minder actief 
wordt. Mogelijk resulteert langere slaapduur in een langdurigere activatie van het 
parasympathische zenuwstelsel, voelt de persoon zich daardoor meer relaxed en wordt hij 
of zij minder actief. De reden dat we geen verband vonden tussen slaapkwaliteit en fysieke 
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activiteit zou kunnen liggen aan het meetinterval: wellicht is verbeterde slaapkwaliteit wel 
degelijk gunstig ten behoeve van fysieke activiteit en andersom, maar heeft dit pas effect op 
de wat langere termijn. Vervolgstudies zouden hierover uitsluitsel kunnen geven. 
In Hoofdstuk 6 richtte de aandacht zich op een groep depressieve deelnemers (N=267) 
die gedurende drie jaar gevolgd werden. Vier keer per jaar werd aan deze personen 
gevraagd welke symptomen van depressie zij per week gedurende de afgelopen drie 
maanden ervaren hadden. Dit design maakte het mogelijk de volgorde van veranderingen 
van slaapproblemen en de kernsymptomen van depressie (symptomen 1 en 2, Box 1) te 
onderzoeken gedurende episodes van depressie en remissie. We onderzochten of de 
aanwezigheid of afwezigheid van slaapproblemen in de huidige week van invloed was 
op het verdwijnen dan wel ontstaan van de kernsymptomen de volgende week, en vice 
versa, en of de aanwezigheid of afwezigheid van de kernsymptomen in de huidige week 
van invloed was op het verdwijnen dan wel ontstaan van het slaapproblemen in de 
daaropvolgende week. We vonden op groepsniveau dat veranderingen in slaapproblemen 
en stemmingssymptomen in beide richtingen aan elkaar gerelateerd waren. De 
aanwezigheid van slaapproblemen in de huidige week vergrootte de kans op het ontstaan 
van kernsymptomen, en verkleinde de kans op het verdwijnen van kernsymptomen de 
daaropvolgende week, en vice versa. Omdat tijdreeksgegevens beschikbaar waren over drie 
jaar, konden we vervolgens onderzoeken of er subgroepen bestonden in het beloop van 
de slaapproblemen en kernsymptomen gedurende drie jaar, en of in deze subgroepen de 
volgorde van veranderingen van deze symptomen verschillend was. Er werden drie 
subgroepen gevonden. De eerste subgroep ‘geen remissie’ bestond uit personen die 
gedurende drie jaar niet opknapten van hun depressie, en waarbij slaap- en 
kernsymptomen aanwezig bleven. De aanwezigheid van slaapproblemen zorgde er in deze 
groep voor dat kernsymptomen moeilijker verdwenen. Andersom had de aanwezigheid van 
kernsymptomen in deze groep geen invloed op de ontwikkeling van de slaapproblemen. De 
tweede subgroep ‘complete remissie’ bestond uit personen die gedurende de drie jaar wel 
opknapten van hun depressie. In deze groep verdwenen de kernsymptomen en de 
slaapproblemen, waarbij de afwezigheid van het ene symptoom ervoor zorgde dat het 
andere symptoom ook sneller verdween. In de derde subgroep ‘gedeeltelijke remissie’ 
knapten de kernsymptomen sneller op dan het slaapsymptoom, en bleef sprake van 
residuele slaapproblemen. De bevindingen in dit hoofdstuk duiden erop dat 
slaapproblemen een rol spelen in het beloop van depressie, maar niet voor iedereen, en 
geven de eerste aanwijzing richting het belang van de behandeling van slaapproblemen bij 
subgroepen van depressieve patiënten. 
Concluderende opmerkingen 
In Hoofdstuk 7 werden de bevindingen uit dit proefschrift besproken en in een breder 
perspectief geplaatst. Binnen de dag en van dag tot dag bleken de dynamiek van melato-
nine en slaap voorspellend voor veranderingen in positief of negatief affect, vermoeidheid 
en fysieke activiteit, maar niet andersom. Van week tot week bleken veranderingen in 
slaapproblemen voorspellend voor veranderingen in kernsymptomen van depressie, en 
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ook andersom. Mogelijk reageert slaap langzamer op veranderingen van positief affect, 
negatief affect, vermoeidheid, en fysieke activiteit dan dat melatonine, positief affect, 
negatief affect, vermoeidheid en fysieke activiteit reageren op veranderingen in slaap, 
waardoor in het kleinere tijdsinterval (van dag tot dag) unidirectionele verbanden 
gevonden werden en in het grotere tijdsinterval (van week tot week) bidirectionele. Een 
andere verklaring voor dit verschil zou kunnen zijn dat slaap minder responsief is en 
dus robuuster en stabieler dan gedacht werd, en meerdere dagen van achtereenvolgende 
verbetering nodig zijn voor een effect op slaap detecteerbaar is. 
De gevonden dynamische verbanden tussen slaap en affect, slaap en fysieke activiteit, 
en slaap en de kernsymptomen van depressie suggereren dat slaap een rol speelt in 
depressie-gerelateerde factoren, zowel bij depressieve als niet-depressieve personen. Deze 
bevindingen suggereren het belang van een benadering waarbij slaap een centralere rol 
krijgt in de preventie en behandeling van depressie. Aangezien uit de resultaten van dit 
proefschrift geen conclusies over causaliteit getrokken kunnen worden, omdat er geen 
gerandomiseerde experimenten werden uitgevoerd, kan geen eenduidige conclusie 
getrokken worden ten aanzien van de rol van slaap in de context van depressie. Omdat er 
weinig aanwijzingen zijn dat een goede nachtrust slecht is voor de geestelijke gezondheid, 
maar wel veel aanwijzingen dat slaapproblemen gerelateerd zijn aan hogere 
gezondheidsrisico’s, kunnen de huidige resultaten gezien worden als aanleiding om 
slaap meer aandacht te geven in de klinische praktijk. Dit zou al kunnen door een simpel 
slaaphygiëne-advies in de klinische praktijk te implementeren, als eerste stap naar een 
meer slaapgerichte behandeling in de klinische praktijk voor mensen met slaapproblemen. 
Sterkere aanbevelingen kunnen gedaan worden met resultaten van studies die 
geschikt zijn om causale verbanden aan te tonen, namelijk experimentele studies. Een 
belangrijk aandachtspunt voor toekomstig onderzoek is causaliteit. Het zou van grote 
toegevoegde waarde zijn te weten of gemanipuleerde veranderingen in slaapkwaliteit of 
-kwantiteit gunstige veranderingen in depressie-gerelateerde factoren, depressie- 
symptomen, of depressiebeloop in gang kunnen zetten. Als helder is op welke manier 
slaap deze factoren beïnvloedt, kan hiervan constructief gebruikt gemaakt worden in de 
preventie en behandeling van depressie. 
Dit proefschrift laat zien dat heterogeniteit waar mogelijk meegenomen moet worden 
in depressieonderzoek, omdat dit resulteert in inzichten over verschillen tussen personen 
die anders onopgemerkt zouden zijn gebleven. Daarnaast pleit de mate van gevonden 
heterogeniteit in dit proefschrift voor op maat gemaakte interventies. De verschillen tussen 
individuen markeren nog eens dat gemiddelde groepsverbanden niet altijd representatief 
zijn voor de sterkte en richting van verbanden op het niveau van het individu. De 
ecologische validiteit van de studies die in dit proefschrift werden gebruikt is groter dan die 
van de meer traditionele benaderingen. Deelnemers verzamelden data in hun natuurlijke 
omgeving, fluctuaties over de tijd konden in kaart worden gebracht en heterogeniteit kon 
worden meegenomen in de analyses. Deze factoren vergrootten de vertaalbaarheid van de 
resultaten naar het dagelijks leven van de onderzoeksdeelnemers. 
Concluderend werd in dit proefschrift gevonden dat slaap een relevante speler lijkt 
in depressie. Desondanks is er een verscheidenheid aan andere factoren die ook een rol 
spelen in de ontwikkeling en het beloop van depressieve episoden, al gaat het buiten dit 
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proefschrift om hierover verder uit te wijden. De bijdrage van slaap is waarschijnlijk 
niet uniek. Zolang in toekomstig onderzoek dynamiek, heterogeniteit en ecologische 
validiteit hoog in het vaandel staan, zullen resultaten ons dichterbij een persoonsgerichte 
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